Academic Staff
| Degree | Department/Program | Institute | Year |
| 1989 | |||
| 1994 | |||
| 2000 | |||
| 2005 |
1. Buji Dilatasyonuna Dirençli Benign Özofagus Darlıklarının Tedavisinde İntralezyonel Steroid İnjeksiyonunun Etkisi, Supervisor: Dr. Ülkü Sarıtaş, Others, Others, Internal Medicine Department, Ankara, Turkey, .
2. Oktreotid; ERCP Sonrası Gelişen Hiperamilazemiyi Engelleyebilir Mi?, Supervisor: Dr. Ahmet Görgül, Gazi University, Others, Internal Medicine Department, Ankara, Turkey, .
http://tez2.yok.gov.tr">http://tez2.yok.gov.tr
| users.gorevturu | users.gorevsirket | Year |
| SIRKET ORTAGI | ALTINBAS OZEL SAGLIK HIZMETLERI VE BILISIM SAN. TIC. LTD.STI. | 2020-07-21 - 2021-06-15 |
| SIRKET ORTAGI | ALTINTAS OZEL SAGLIK HIZMETLERI VE BILISIM SAN TIC LTD STI | 2019-06-15 - 2020-06-14 |
| SIRKET SAHIBI | 2018-06-15 - 2019-06-15 |
| Title | Dutie | Institution/Other | Year |
| 2017-02-27 - Continue | |||
| 2017-02-27 - Continue | |||
| 2015-01-20 - Continue | |||
| COMMISION | RADIATION SAFETY BOARD | MERSIN UNIVERSITY FACULTY OF MEDICINE SAUM | 2009-01-01 - Continue |
| COMMISION | NUTRITION TEAM | MERSIN UNIVERSITY FACULTY OF MEDICINE SAUM | 2006-05-07 - Continue |
| 2019-07-26 - 2022-07-26 | |||
| 2017-01-11 - 2020-01-11 | |||
| 2017-01-11 - 2020-01-11 |
2020
1. AKKUZU, M.; SEZGİN, O.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E. . MEDICAL BULLETIN OF HASEKI, 2020, 58, 15-20. 0 + 010.4274/haseki.galenos.2019.5263
2023
96. ALTINTAŞ, E. . ELSEVIER BV, 2023, , -. 1000 + 0
95. ALTINTAŞ, E. . ELSEVIER BV, 2023, 165, -. 1000 + 0
94. ALTINTAŞ, E. . MASSACHUSETTS MEDICAL SOCIETY, 2023, 388, -. 1000 + 0
93. ALTINTAŞ, E. . ELSEVIER BV, 2023, 21, -. 1000 + 0
92. ALTINTAŞ, E. . SPRINGER SCIENCE AND BUSINESS MEDIA LLC, 2023, 13, -. 1000 + 0
2022
91. AKKUZU, M.; ALTINTAŞ, E.; YARAŞ, S.; SEZGİN, O.; ATEŞ, F.; ÜÇBİLEK, E.; ÖZDOĞAN, O. . MDPI AG, 2022, 59, 70-76. 700 + 0
90. ALTINTAŞ, E. . THE TURKISH JOURNAL OF GASTROENTEROLOGY : THE OFFICIAL JOURNAL OF TURKISH SOCIETY OF GASTROENTEROLOGY, 2022, 33, 286-. 1000 + 0
2021
89. ALTINTAŞ, E. . JOURNAL OF CROHN'S AND COLITIS, 2021, 15, -. 1000 + 0
88. SEZGİN, O.; BOZTEPE, B.; ÜÇBİLEK, E.; ALTINTAŞ, E.; çelikcan, h. . THE TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32, 870-878. 600 + 0
87. ALTINTAŞ, E. . INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75, -. 1000 + 0
2020
86. ALTINTAŞ, E. . INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 95, 84-89. 1000 + 0
85. ALTINTAŞ, E. . PANCREATOLOGY, 2020, 20, 1323-1331. 1000 + 0
84. ALTINTAŞ, E. . PANCREATOLOGY, 2020, 20, 1323-1331. 1000 + 0
83. YARAŞ, S.; SEZGİN, O.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; ALTINTAŞ, E. . THE TURKISH JOURNAL OF GASTROENTEROLOGY, 2020, 31, 142-147. 500 + 0
82. ALTINTAŞ, E. . INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2020, , -. 1000 + 0
81. ÖZDOĞAN, O.; YARAŞ, S.; ATEŞ, F.; ÜÇBİLEK, E.; SEZGİN, O.; ALTINTAŞ, E. . TURKISH JOURNAL OF GASTROENTEROLOGY, 2020, 31, 384-392. 400 + 0
80. ALTINTAŞ, E. . THE TURKISH JOURNAL OF GASTROENTEROLOGY, 2020, 31, 1-41. 1000 + 0
79. YARAŞ, S.; SEZGİN, O.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; ALTINTAŞ, E. . TURKISH JOURNAL OF GASTROENTEROLOGY, 2020, 31, 142-147. 500 + 0
2019
78. ALTINTAŞ, E. . ONCOLOGY, 2019, 96, 25-32. 1000 + 0
77. Sezgin, O.; Ozdogan, O.; Yaras, S.; Ucbilek, E.; Altintas, E. Evaluation of hypertriglyceridemia-induced acute pancreatitis: A single tertiary care unit experience from Turkey. AVES PUBLISHING CO., 2019, 30, 271-277. 500 + 0
76. ALTINTAŞ, E. . NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381, 1215-1226. 1000 + 0
75. YARAŞ, S.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O. . TURKISH JOURNAL OF GASTROENTEROLOGY, 2019, 30, 331-335. 450 + 0
74. SEZGİN, O.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ALTINTAŞ, E. . TURKISH JOURNAL OF GASTROENTEROLOGY, 2019, 30, 271-277. 500 + 0
73. Yaras, S.; Ucbilek, E.; Ozdogan, O.; Ates, F.; Altintas, E.; Sezgin, O. Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey. AVES PUBLISHING CO., 2019, 30, 331-335. 450 + 0
72. ALTINTAŞ, E. . NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381, 1215-1226. 1000 + 0
71. Sands, B.; Peyrin-Biroulet, L.; Loftus, E.; Danese, S.; Colombel, J.; Törüner, M.; Jonaitis, L.; Abhyankar, B.; Chen, J.; Rogers, R. Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis. MASSACHUSETTS MEDICAL SOCIETY, 2019, 381, 1215-1226. 0 + 0
70. YARAŞ, S.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O. . THE TURKISH JOURNAL OF GASTROENTEROLOGY, 2019, 29, 11-16. 450 + 0
2018
69. Akkiz, H.; Carr, B.; Yalçın K., K.; Guerra, V.; Kuran, S.; Altıntaş, E.; Üsküdar, O.; Karaoğullarından, Ü.; Özakyol, A.; Tokmak, S. Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients. ONCOLOGY, 2018, 93, 1-9. 150 + 0
68. ALTINTAŞ, E. . CLINICAL PRACTICE, 2018, 625, 15-. 1000 + 0
67. ALTINTAŞ, E. . CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018, 1-8. 1000 + 0
66. SEZGİN, O.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ALTINTAŞ, E. . TURKISH JOURNAL OF GASTROENTEROLOGY, 2018, 9, 21-27. 500 + 0
65. ALTINTAŞ, E. . ONCOLOGY, 2018, 94, 116-124. 1000 + 0
64. ALTINTAŞ, E. . THE LANCET GASTROENTEROLOGY HEPATOLOGY, 2018, 3, 383-403. 1000 + 0
63. ALTINTAŞ, E. . CLIN PRACT (LOND), 2018, 15, 453-464. 1000 + 0
62. ALTINTAŞ, E. . CLINICAL PRACTICE, 2018, 15, -. 1000 + 0
61. ALTINTAŞ, E. . CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018, -. 1000 + 0
2017
60. SEZGİN, O.; YARAŞ, S.; ATEŞ, F.; ALTINTAŞ, E.; SARITAŞ, B. . EUROASIAN J HEPATOGASTROENTEROL., 2017, , -. 600 + 0
59. SÖYLEMEZ, F.; İZCİ AY, Ö.; AY, M.; ALTINTAŞ, E.; TÜRKSEVEN, Ç.; ERDAL, M. . BRATISLAVA MEDICAL JOURNAL, 2017, 118, 695-701. 550 + 0
58. Soylemez, F.; Ay, Ö.; Ay, E.; Altıntaş, E.; Türkseven, Ç.; Erdal, M. Effect of EGF on Bax, Bcl-2 and Fas expression in ulcerous disease and N87 cell line. BRATISLAVA MEDICAL JOURNAL, 2017, 118, 695-701. 550 + 0
2016
57. Üçbilek, E.; Abaylı, B.; Bakır Koyuncu, M.; Mıdıklı, D.; Gözüküçük, S.; Akdağ, A.; Özdoğan, O.; Altıntaş, E.; Sezgin, O. Distribution of hepatitis C virus genotypes among intravenous drug users in the Çukurova region of Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES , 2016, 46, 66-71. 100 + 0
2015
56. Altintas, Z.; Ucbilek, E.; Erdal, M.; Sezgin, O.; Altintas, E. Methylation and Expression of the Genes That Have a Role in the Wnt Signaling Pathway in Ulcerative Colitis. GASTROENTEROLOGY, 2015, 148, S694-S694. 500 + 0
55. Oksuz, Z.; Serin, M.; Kaplan, E.; Dogen, A.; Tezcan, S.; Aslan, G.; Emekdas, G.; Sezgin, O.; Altintas, E.; Tiftik, E. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. MOLECULAR BIOLOGY REPORTS, 2015, 42, 713-720. 100 + 25
Times Cited: 5
54. Sezgin, O.; Altintas, E.; Ates, F.; Yaras, S.; Saritas, B.; Aydin, K. Air cholangiogram is not sufficent to detect common bile duct stones during ERCP. AVES PUBLISHING CO., 2015, 25, 319-320. 750 + 0
53. Tezcan, S.; Ulger, M.; Ucbilek, E.; Aslan, G.; Serin, M.; Sezgin, O.; Delialioglu, N.; Altintas, E.; Helvaci, I.; Emekdas, G. Characterization of Basal Core Promoter/Precore Gene Mutations in Chronically Infected Patients with Hepatitis B Virus Genotype D in Mersin Province, Turkey. MIKROBIYOLOJI BULTENI, 2015, 49, 377-392. 100 + 0
2014
52. Sezgin, O.; Barlas, I.; Ucbilek, E.; Yengel, E.; Altintas, E. Modified sequential Helicobacter Pylori eradication therapy using high dose omeprazole and amoxicillin in the initial phase in the extensive metaboliser turkish patients for CYP2C19 polymorphism is ineffective. ACTA GASTRO-ENTEROLOGICA BELGICA, 2014, 77, 3-7. 500 + 0
51. Altintas, E.; Altintas, Z.; Sezgin, O.; Ucbilek, E.; Nayir, E.; Erdal, M.; Polat, A.; Orekeci, G. Polymorphisms in methylenetetrahydrofolate reductase gene: Their impact on liver steatosis and fibrosis of chronic hepatitis c patients. SCIENTIFIC RESEARCH PUBLISHING, INC,, 2014, 04, 73-80. 750 + 0
50. Giray, B.; Emekdas, G.; Tezcan, S.; Ulger, M.; Serin, M.; Sezgin, O.; Altintas, E.; Tiftik, E. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma. MOLECULAR BIOLOGY REPORTS, 2014, 41, 4513-4519. 160 + 45
Times Cited: 9
49. Turgutalp, K.; Tabakan, F.; Kara, T.; Gubur, O.; Altintas, E.; Turkmenoglu, O.; Ozhan, O.; Kiykim, A.; Apaydin, F. An unusual cause of duodenal obstruction: Mesenteric fibromatosis in a patient with type I Mayer-Rokitansky-Kuster-Hauser syndrome. AVES PUBLISHING CO., 2014, 25, 92-95. 300 + 0
48. Turgutalp, K.; Tabakan, F.; Kara, T.; Gubur, O.; Altintas, E.; Turkmenoglu, O.; Ozhan, O.; Kiykim, A.; Apaydin, F. An unusual cause of duodenal obstruction: Mesenteric fibromatosis in a patient with type I Mayer-Rokitansky-Kuster-Hauser syndrome. TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25, 92-95. 300 + 0
47. Oksuz, Z.; Serin, M.; Kaplan, E.; Dogen, A.; Tezcan, S.; Aslan, G.; Emekdas, G.; Sezgin, O.; Altintas, E. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. SPRINGER SCIENCE + BUSINESS MEDIA, 2014, 42, 713-720. 100 + 0
46. Sezgin, O.; Altintas, E.; Ates, F.; Yaras, S.; Saritas, B.; Aydin, K. Air cholangiogram is not sufficent to detect common bile duct stones during ERCP. TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25, 319-320. 750 + 0
2013
45. Ucbilek, E.; Sezgin, O.; Altintas, E. Low Dose Bolus Pantoprazole Following Succesful Endoscopic Treatment for Acute Peptic Ulcer Bleeding Is Effective: A Randomised, Prospective, Double-Blind, Double Dummy Pilot Study. GASTROENTEROLOGY, 2013, 144, S506-S506. 1000 + 5
Times Cited: 1
44. Sezgin, O.; Yaras, S.; Saritas, B.; Ates, F.; Altintas, E. How Should Be Applied the Premedication in Percutanous Liver Biopsy? : The Roles of Analghesics and Sedatives. GASTROENTEROLOGY, 2013, 144, S450-S450. 500 + 0
43. Dogen, A.; Kaplan, E.; Serin, M.; Oksuz, Z.; Tezcan, S.; Aslan, G.; Sezgin, O.; Altintas, E.; Emekdas, G. Detection of hepatitis B virus X gene and PreC promoter mutations from chronic hepatitis B patients in the south of Turkey. MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2013, 28, 74-78. 100 + 0
42. Tezcan, S.; Ulger, M.; Aslan, G.; Yaras, S.; Altintas, E.; Sezgin, O.; Emekdas, G.; Gurer Giray, B.; Sungur, M. Determination of Hepatitis C Virus Genotype Distribution in Mersin Province, Turkey. MIKROBIYOLOJI BULTENI, 2013, 47, 332-338. 300 + 40
Times Cited: 8
2012
41. Akkiz, H.; Sezgin, O.; Altintas, E.; Yalcin, K.; Ekin, N.; Uskudar, O.; Sandikci, M.; Bayram, S.; Bekar, A.; Akgollu, E. Association between IL28B gene polymorphism (rs12979860) and sustained virological response in patients infected with hepatitis C virus Genotype 1. HEPATOLOGY, 2012, 56, 1051A-1051A. 450 + 0
40. Emekdas, G.; Tezcan, S.; Aslan, G.; Serin, M.; Sezgin, O.; Ucbilek, E.; Ulger, M.; Altintas, E.; Dogen, A. Determination of Hepatitis B Virus Genotypes in Chronic Hepatitis B Patients in Mersin Province, Turkey. MIKROBIYOLOJI BULTENI, 2012, 46, 432-445. 100 + 10
Times Cited: 2
2010
39. Sezgin, O.; Altintas, E.; Ucbilek, E. Ectopic opening of the common bile duct into the stomach. TURKISH JOURNAL OF GASTROENTEROLOGY, 2010, 21, 163-167. 1000 + 0
38. Sezgin, O.; Altintas, E.; Ucbilek, E.; Tombak, A. Percutaneous Liver Biopsies: Safety and Efficacy. TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2010, 30, 1287-1291. 850 + 5
Times Cited: 1
37. Serin, M.; Bekiroglu, E.; Polat, S.; Dogen, A.; Tezcan, S.; Aslan, G.; Sezgin, O.; Altintas, E.; Emekdas, G.; Ucbilek, E. Detection of Hepatitis B Virus Polymerase Gene Variants Associated with Lamivudine, Adefovir and Entecavir Resistance and Some Undefined Mutations Isolated from Chronic Hepatitis B Patients in the South of Turkey. MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2010, 25, 178-182. 100 + 5
Times Cited: 1
36. Sezgin, O.; Altintas, E.; Tombak, A.; Ucbilek, E. Fasciola hepatica-induced acute pancreatitis: Report of two cases and review of the literature. TURKISH JOURNAL OF GASTROENTEROLOGY, 2010, 21, 183-187. 850 + 15
Times Cited: 3
35. Sezgin, O.; Altintas, E.; Ucbilek, E. Ectopic opening of the common bile duct into various sites of the upper digestive tract: a case series. GASTROINTESTINAL ENDOSCOPY, 2010, 72, 198-203. 1000 + 0
2009
34. Sezgin, O.; Altintas, E.; Polat, A.; Tombak, A. Ultrasonographic features of a large B-cell lymphoma of the gallbladder. TURKISH JOURNAL OF GASTROENTEROLOGY, 2009, 20, 239-240. 850 + 5
Times Cited: 1
33. Altintas, E.; Senli, M.; Polat, A.; Sezgin, O. A case of Behcet's disease presenting with massive lower gastrointestinal bleeding. TURKISH JOURNAL OF GASTROENTEROLOGY, 2009, 20, 57-61. 950 + 20
Times Cited: 4
32. Ozturhan, H.; Emekdas, G.; Sezgin, O.; Korkmaz, M.; Altintas, E. Seroepidemiology of Fasciola Hepatica in Mersin province and surrounding towns and the role of family history of the Fascioliasis in the transmission of the parasite. TURKISH JOURNAL OF GASTROENTEROLOGY, 2009, 20, 198-203. 500 + 35
Times Cited: 7
2008
31. Altintas, E.; Senli, M.; Sezgin, O. Prevalence of celiac disease among dyspeptic patients: A community-based case-control study. TURKISH JOURNAL OF GASTROENTEROLOGY, 2008, 19, 81-84. 1000 + 20
Times Cited: 4
30. Altintas, E.; Uecbilek, E.; Sezgin, O.; Sayici, Y. Alverine citrate plus simethicone reduces cecal intubation time in colonoscopy - A randomized study. TURKISH JOURNAL OF GASTROENTEROLOGY, 2008, 19, 174-179. 950 + 30
Times Cited: 6
29. Sezgin, O.; Aslan, G.; Altintas, E.; Tezcan, S.; Serin, M.; Emekdas, G. Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey. TURKISH JOURNAL OF GASTROENTEROLOGY, 2008, 19, 163-167. 650 + 115
Times Cited: 23
2007
28. Altintas, E.; Sezgin, O.; Cinel, L. Watermelon colon: Is there an association with alcohol?. MEDICAL SCIENCE MONITOR, 2007, 13, CS137-CS140. 1000 + 15
Times Cited: 3
27. Sezgin, O.; Altintas, E.; Tombak, A. Effects of seasonal variations on acute upper gastrointestinal bleeding and its etiology. TURKISH JOURNAL OF GASTROENTEROLOGY, 2007, 18, 172-176. 1000 + 25
Times Cited: 5
26. Sezgin, O.; Altintas, E.; Nayir, E.; Uecbilek, E. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey. HELICOBACTER, 2007, 12, 629-632. 850 + 65
Times Cited: 13
25. Sezgin, O.; Altintas, E.; Uecbilek, E.; Tombak, A.; Tellioglu, B. Low efficacy rate of moxifloxacin-containing Helicobacter pylori eradication treatment: In an observational study in a turkish population. HELICOBACTER, 2007, 12, 518-522. 800 + 60
Times Cited: 12
2006
24. Sezgin, O.; Altintas, E.; Ucbilek, E.; Tataroglu, C. Bismuth-based therapies for the first step eradication of Helicobacter pylori.. THE TURKISH JOURNAL OF GASTROENTEROLOGY : THE OFFICIAL JOURNAL OF TURKISH SOCIETY OF GASTROENTEROLOGY, 2006, 17, 90-3. 850 + 30
Times Cited: 6
23. Altintas, E.; Sayici, Y.; Sezgin, O. Endoscopic epinephrine injection induced amaurosis fugax. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21, 1505-1506. 1000 + 5
Times Cited: 1
22. Altintas, E.; Sezgin, O.; Uyar, B.; Polae, A. Acute upper gastrointestinal bleeding due to metastatic lung cancer: An unusual case. YONSEI MEDICAL JOURNAL, 2006, 47, 276-277. 950 + 30
Times Cited: 6
2005
21. Sezgin, O.; Altintas, E.; Saritas, U.; Sahin, B. Hepatic alveolar echinococcosis - Clinical and radiologic features and endoscopic management. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39, 160-167. 850 + 75
Times Cited: 15
20. Oguz, D.; Cicek, B.; Filik, L.; Odemis, B.; Kilic, M.; Altintas, E.; Zengin, N.; Altiparmak, E. Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1). WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11, 580-583. 250 + 30
Times Cited: 6
19. Avlan, D.; Nayci, A.; Altintas, E.; Cingi, E.; Sezgin, O.; Aksoyek, S. An unusual cause for massive upper gastrointestinal bleeding in children: Dieulafoy's lesion. PEDIATRIC SURGERY INTERNATIONAL, 2005, 21, 417-418. 650 + 25
Times Cited: 5
18. Tunc, B.; Filik, L.; Altintas, E.; Turhan, N.; Ulker, A.; Dagli, U. Mucosal mast cells in irritable bowel syndrome and inflammatory bowel disease.. ACTA MEDICA (HRADEC KRALOVE) / UNIVERSITAS CAROLINA, FACULTAS MEDICA HRADEC KRALOVE, 2005, 48, 163-4. 650 + 20
Times Cited: 4
2004
17. Sezgin, O.; Altintas, E.; Disibeyaz, S.; Saritas, U.; Sahin, B. Hepatobiliary fascioliasis - Clinical and radiologic features and endoscopic management. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38, 285-291. 800 + 90
Times Cited: 18
16. Altintas, E.; Sezgin, O. S-adenosylhomocysteine hydrolase, S-adenosylmethionine, S-adenosylhomocysteine: correlations with ribavirin induced anemia. MEDICAL HYPOTHESES, 2004, 63, 834-837. 1000 + 25
Times Cited: 5
15. Altintas, E.; Sezgin, O.; Kacar, S.; Tunc, B.; Parlak, E.; Altiparmak, E.; Saritas, U. Esophageal variceal ligation for acute variceal bleeding: results of three years' follow-up.. THE TURKISH JOURNAL OF GASTROENTEROLOGY : THE OFFICIAL JOURNAL OF TURKISH SOCIETY OF GASTROENTEROLOGY, 2004, 15, 27-33. 800 + 0
14. Altintas, E.; Sezgin, O.; Ulu, O.; Aydin, O.; Camdeviren, H. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10, 1656-1658. 900 + 185
Times Cited: 37
13. Altintas, E.; Akkus, N.; Gen, R.; Helvaci, M.; Sezgin, O.; Oguz, D. Effects of terlipressin on systolic pulmonary artery pressure of patients with liver cirrhosis: An echocardiographic assessment. WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10, 2278-2280. 850 + 30
Times Cited: 6
12. Altintas, E.; Ulu, O.; Sezgin, O.; Aydin, O.; Camdeviren, H. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.. THE TURKISH JOURNAL OF GASTROENTEROLOGY : THE OFFICIAL JOURNAL OF TURKISH SOCIETY OF GASTROENTEROLOGY, 2004, 15, 90-3. 900 + 25
Times Cited: 5
11. Altintas, E.; Oguz, D.; Kacar, S.; Ozderin, Y.; Sezgin, O.; Zengin, N. Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia.. THE TURKISH JOURNAL OF GASTROENTEROLOGY : THE OFFICIAL JOURNAL OF TURKISH SOCIETY OF GASTROENTEROLOGY, 2004, 15, 49-52. 850 + 15
Times Cited: 3
10. Altintas, E.; Kacar, S.; Tunc, B.; Sezgin, O.; Parlak, E.; Altiparmak, E.; Saritas, U.; Sahin, B. Intralesional steroid injection in benign esophageal strictures resistant to bougie dilation. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19, 1388-1391. 750 + 225
Times Cited: 45
9. Altintas, E.; Sayici, Y.; Sezgin, O.; Aydin, O. Initial presentation of hepatocellular carcinoma as a subcutaneous mass on the anterior chest wall. DIGESTIVE DISEASES AND SCIENCES, 2004, 49, 651-652. 950 + 5
Times Cited: 1
8. Tiftik, N.; Altintas, E.; Kiykim, A.; Ucbilek, E.; Sezgin, O. Long-term red blood cell exchange can be used to successfully treat sickle cell intrahepatic cholestasis: A case report. JOURNAL OF CLINICAL APHERESIS, 2004, 19, 17-19. 800 + 25
Times Cited: 5
2003
7. Kiykim, A.; Uyar, B.; Altintas, E.; Sezer, K.; Pata, C.; Yazar, A. Successful treatment of acute hepatic injury caused by paracetamol intoxication in a late-referral patient by N-acetylcysteine. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36, 372-373. 650 + 0
6. Tiftik, N.; Kiykim, A.; Altintas, E.; Sezer, K.; Doruk, N.; Sezgin, O.; Seyrek, E.; Buyukafsar, K.; Oral, U. Therapeutic plasma exchange for multidrug intoxication: A case report. JOURNAL OF CLINICAL APHERESIS, 2003, 18, 132-133. 500 + 5
Times Cited: 1
5. Altintas, E.; Tiftik, E.; Ucbilek, E.; Sezgin, O. Sickle cell anemia connected with chronic intrahepatic cholestasis: a case report.. THE TURKISH JOURNAL OF GASTROENTEROLOGY : THE OFFICIAL JOURNAL OF TURKISH SOCIETY OF GASTROENTEROLOGY, 2003, 14, 215-8. 950 + 20
Times Cited: 4
4. Pata, C.; Yazar, A.; Altintas, E.; Polat, G.; Aydin, O.; Tiftik, N.; Konca, K. Serum levels of intercellular adhesion molecule-1 and nitric oxide in patients with chronic hepatitis related to hepatitis C virus: Connection fibrosis. HEPATO-GASTROENTEROLOGY, 2003, 50, 794-797. 600 + 55
Times Cited: 11
3. Sezgin, O.; Oguz, D.; Altintas, E.; Saritas, K.; Sahin, B. Endoscopic management of biliary obstruction caused by cavernous transformation of the portal vein. GASTROINTESTINAL ENDOSCOPY, 2003, 58, 602-608. 700 + 145
Times Cited: 29
2. Kiykim, A.; Altintas, E.; Sezgin, O.; Sezer, K.; Tiftik, N.; Akbay, E.; Seyrek, E.; Konca, K. Valsartan-induced hepatotoxicity in a HBs-Ag-positive patient. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98, 507-507. 325 + 25
Times Cited: 5
1994
1. HASANOGLU, E.; ALTAN, N.; SINDEL, S.; ONGUN, C.; BALI, M.; ALTINTAS, E. THE RELATIONSHIP BETWEEN ERYTHROCYTE SUPEROXIDE-DISMUTASE ACTIVITY AND PLASMA-LEVELS OF SOME TRACE-ELEMENTS (AL, CU, ZN) OF DIALYSIS PATIENTS. GENERAL PHARMACOLOGY, 1994, 25, 107-110. 400 + 70
Times Cited: 14
2019
10. Kara, T.; Serinsöz, E.; Bozdoğan Arpacı, R.; Emek Yüksek, G.; Polat, Y.; Örekeci, G.; Usta, Y.; ALTINTAS, E. C-kit expression and potential role of iNOS, COX-2, and ICAM-3 in Giardiasis. ANNALS OF GASTROENTEROLOGY AND THE DIGESTIVE SYSTEM, 2019, 2, 1-4. 20 + 0
9. Karabulut, Ü.; Bakır Koyuncu, M.; Sezgin, O.; Üçbilek, E.; Aydın, M.; Altıntaş, E. Early Oral Refeeding andSelection of Initial Diet in MildAcute Pancreatitis. JAPANESE JOURNAL OF GASTROENTEROLOGY ANDHEPATOLOGY, 2019, 1, 1-5. 80 + 0
8. Altintas, E.; Yalin, S.; Sezgin, O.; Ucbilek, E.; Tombak, A.; Kanik, A. Erythrocyte Membrane Protein Band 3 Predicts Interferon Ribavirin-Induced Anemia. SCIENTIFIC RESEARCH PUBLISHING, INC,, 2019, 08, 5-16. 170 + 0
2017
7. Sezgin, O.; Yaraş, S.; Ateş, F.; Altıntaş, E.; Sarıtaş, B. Effectiveness of Sedoanalgesia in Percutaneous Liver Biopsy Premedication. EUROASIAN J HEPATOGASTROENTEROL., 2017, 7, 146-149. 120 + 0
6. Altıntaş, E.; Üçbilek, E.; Ateş, F.; Sezgin, O.; Bakır Koyuncu, M. Recurrent Peritonitis with Bowel Involvement Mimicking Bowel Ischemia. INTERNATIONAL JOURNAL OF RADIOLOGY & RADIATION THERAPY, 2017, 2, 1-2. 90 + 0
2016
5. O, S. Addition of Rifaximin and N-Acetyl Cysteine to the Standard Helicobacter pylori Treatment Regimens: Is it Possible to Improve Outcomes?. SCI FORSCHEN, INC., 2016, 2, 1-5. 0 + 0
2015
4. Ucbilek, E.; Sezgin, O.; Altintas, E. LOW DOSE BOLUS PANTOPRAZOLE FOR ACUTE PEPTIC ULCER BLEEDING IS EFFECTIVE. ACTA MEDICA MEDITERRANEA, 2015, 31, 91-96. 200 + 0
2014
3. Altintas, E.; Yaras, S.; Cimen, B.; Ucbilek, E.; Saritas, B.; Ates, F.; Sezgin, O.; Temel, G. Chitotriosidase Activity in Different Stages of Hepatitis C. It may a Possible Tumor Marker for Hepatocellular Carcinoma. JOURNAL OF CANCER TREATMENT AND RESEARCH, 2014, 2, 5-8. 150 + 0
2013
2. Mert Altintas, Z. The Effect of Genetic Variations of Methylene Tetrahydropholate Reductase Gene Polymorphisms on Ribavirin-Induced Anemia in Hepatitis C Patients. OMICS PUBLISHING GROUP, 2013, 02, 1-8. 0 + 0
1. Mert Altintas, Z. The Effect of Genetic Variations of Methylene Tetrahydropholate Reductase Gene Polymorphisms on Ribavirin-Induced Anemia in Hepatitis C Patients. OMICS PUBLISHING GROUP, 2013, 02, 0-0. 0 + 0
2022
14. HELVACI, M.; ALTINTAŞ, E.; YAPRAK, M.; DAVRAN, R.; Abyad, A.; Pocok, L. . MIDDLE EAST JOURNAL OF NURSING, 2022, , -. 75 + 0
13. HELVACI, M.; ALTINTAŞ, E.; Canda, M.; Abyad, A.; Pocok, L. . MIDDLE EAST JOURNAL OF AGE AND AGEING, 2022, , -. 80 + 0
12. HELVACI, M.; salaz, s.; ALTINTAŞ, E.; Abyad, A.; Pocok, L. . ADVANCED RESEARCH IN GASTROENTEROLOGY & HEPATOLOGY, 2022, , -. 70 + 0
11. HELVACI, M.; ALTINTAŞ, E.; YAPRAK, M.; DAVRAN, R.; Abyad, A.; Pocok, L. . MIDDLE EAST JOURNAL OF AGE AND AGEING., 2022, 16, 14-19. 75 + 0
10. HELVACI, M.; ALTINTAŞ, E.; YALÇIN, A.; Abyad, A.; Pocok, L. . MIDDLE EAST JOURNAL OF NURSING, 2022, , -. 80 + 0
2021
9. ALTINTAŞ, E. . OPEN ACCESS TEXT PVT, LTD., 2021, 7, -. 100 + 0
8. AKKIZ, H.; ALTINTAŞ, E. . JOURNAL OF TRANSLATIONAL SCIENCE, 2021, 7, -. 100 + 0
7. HELVACI, M.; ALTINTAŞ, E.; YALÇIN, A.; MÜFTÜOĞLU, O.; Abyad, A.; Pocok, L. . WORLD FAMILY MEDICINE/MIDDLE EAST JOURNAL OF FAMILY MEDICINE, 2021, 19, 43-49. 75 + 0
2020
6. ALTINTAŞ, E. . JOURNAL OF TRANSLATIONAL SCIENCE, 2020, , 1-6. 100 + 0
2019
5. AKKUZU, M.; SEZGİN, O.; YARAŞ, S.; ÖZDOĞAN, O.; YILMAZ, İ.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E. . SISLI ETFAL HASTANESI TIP BULTENI / THE MEDICAL BULLETIN OF SISLI HOSPITAL, 2019, , -. 10 + 0
4. KARABULUT, Ü.; KOYUNCU, M.; SEZGİN, O.; ÜÇBİLEK, E.; aydın, M.; ALTINTAŞ, E. . JAPANESE JOURNAL OF GASTROENTEROLOGY ANDHEPATOLOGY, 2019, 5, 1-5. 40 + 0
3. karabulut, u.; KOYUNCU, M.; SEZGİN, O.; ÜÇBİLEK, E.; aydın, m.; ALTINTAŞ, E. . JAPANESE JOURNAL OF GASTROENTEROLOGY ANDHEPATOLOGY, 2019, 1, 1-5. 40 + 0
2017
2. ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O.; ALTINTAŞ, E.; KOYUNCU, M. . INTERNATIONAL JOURNAL OF RADIOLOGY RADIATION THERAPY, 2017, 2, 1-2. 0 + 0
2016
1. SEZGİN, O.; aydın, k.; ATEŞ, F.; ALTINTAŞ, E.; ÜÇBİLEK, E.; YARAŞ, S.; KOYUNCU, M.; Örekeci, g. . JOURNAL OF GASTRIC DISORDERS AND THERAPY ( ISSN 2381-8689 ), 2016, 2, -. 45 + 0
2020
11. AKKUZU, M.; ALTINTAŞ, E.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; AYDIN, F.; RIZAOĞLU BALCI, H.; DİRİK, Y.; SEZGİN, O. . EASTERN JOURNAL OF MEDICINE, 2020, 25, 535-539. 55 + 0
10. ALTINTAŞ, E.; KOYUNCU, M.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O. . JAPANESE JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 4, 1-6. 85 + 0
2019
9. AKKUZU, M.; SEZGİN, O.; YARAŞ, S.; ÖZDOĞAN, O.; YILMAZ, İ.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E. . THE MEDICAL BULLETIN OF SISLI HOSPITAL, 2019, 53, 366-370. 10 + 0
8. AKKUZU, M.; SEZGİN, O.; YARAŞ, S.; ÖZDOĞAN, O.; YILMAZ, İ.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E. . SISLI ETFAL HASTANESI TIP BULTENI / THE MEDICAL BULLETIN OF SISLI HOSPITAL, 2019, 53, 366-370. 10 + 0
7. AKKUZU, M.; SEZGİN, O.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E. . ISTANBUL MEDICAL JOURNAL, 2019, 20, 472-476. 20 + 0
6. ALTINTAŞ, E. . JOURNAL OF TRANSLATIONAL SCIENCE, 2019, 5, -. 100 + 0
5. ALTINTAŞ, E.; YALIN, S.; SEZGİN, O.; ÜÇBİLEK, E.; TOMBAK, A.; KANIK, E. . OPEN JOURNAL OF REGENERATIVE MEDICINE, 2019, 8, 5-16. 85 + 0
4. KARA, T.; Serinsöz, T.; BOZDOĞAN ARPACI, R.; Yüksek, G.; POLAT, Y.; OREKİCİ TEMEL, G.; USTA, Y.; ALTINTAŞ, E. . ANNALS OF GASTROENTEROLOGY AND THE DIGESTIVE SYSTEM, 2019, 2, 1-4. 10 + 0
2018
3. ALTINTAŞ, E. . CLINICAL PRACTICE, 2018, 15, 625-634. 100 + 0
2. ALTINTAŞ, E. . CLINICAL PRACTICE, 2018, 15, 453-464. 100 + 0
1. ALTINTAŞ, E. . JOURNAL OF TRANSLATIONAL SCIENCE, 2018, 5, -. 100 + 0
2023
40. AYDIN, M.; ALTINTAŞ, E. . GUNCEL GASTROENTEROLOJI, 2023, 0, 117-123. 200 + 0
2022
39. KARABULUT, F.; İDİLMAN, R.; SONSUZ, A.; AKDOĞAN KAYHAN, M.; KARABULUT, Ü.; AKKIZ, H.; ALTINTAŞ, E. . HEPATOLOGY FORUM, 2022, 3, 71-. 40 + 0
38. HARPUT, Z.; ALTINTAŞ, E. . TURKIYE KLINIKLERI GASTROENTEROHEPATOLOGY, 2022, , 1-6. 200 + 0
2021
37. AKKUZU, M.; SEZGİN, O.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O.; ATEŞ, F.; AYDIN, F.; RIZAOĞLU BALCI, H.; ALTINTAŞ, E. . ISTANBUL MEDICAL JOURNAL, 2021, 22, 100-104. 20 + 0
36. AKKUZU, M.; SEZGİN, O.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; AYDIN, F.; RIZAOĞLU BALCI, H.; ATEŞ, F.; ALTINTAŞ, E. . KOCAELI MEDICAL JOURNAL, 2021, 10, 72-77. 20 + 0
35. AKKUZU, M.; SEZGİN, O.; ATEŞ, F.; ÖZDOĞAN, O.; YARAŞ, S.; AYDIN, F.; RIZAOĞLU BALCI, H.; ÜÇBİLEK, E.; ALTINTAŞ, E. . MUSTAFA KEMAL UNIVERSITESI TIP DERGISI, 2021, 42, 5-9. 20 + 0
34. AKKUZU, M.; SEZGİN, O.; YARAŞ, S.; ÖZDOĞAN, O.; RIZAOĞLU BALCI, H.; AYDIN, F.; ÜÇBİLEK, E.; ALTINTAŞ, E.; ATEŞ, F. . MUSTAFA KEMAL UNIVERSITESI TIP DERGISI, 2021, 42, 29-33. 20 + 0
2020
33. AKKUZU, M.; SEZGİN, O.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; AYDIN, F.; RIZAOĞLU BALCI, H.; YARAŞ, S.; ATEŞ, F.; ALTINTAŞ, E. . MUSTAFA KEMAL UNIVERSITESI TIP DERGISI, 2020, 11, 109-112. 20 + 0
32. BOZDOĞAN, M.; ATEŞ, F.; AKKUZU, M.; YARAŞ, S.; SEZGİN, O.; YILMAZ, İ.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ALTINTAŞ, E. . MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI, 2020, 13, 155-157. 0 + 0
31. AKKUZU, M.; SEZGİN, O.; ÖZDOĞAN, O.; YARAŞ, S.; BOZKURT BABUŞ, S.; ÜÇBİLEK, E.; ALTINTAŞ, E.; ATEŞ, F. . VAN SAG BIL DERG, 2020, 13, 1-5. 32 + 0
2019
30. ŞEN, Ş.; YARAŞ, S.; AKKUZU, M.; SEZGİN, O.; YILMAZ, İ.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E. . MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI, 2019, 12, 553-556. 0 + 0
29. ŞEN, Ş.; YARAŞ, S.; AKKUZU, M.; SEZGİN, O.; YILMAZ, İ.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E. . MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI, 2019, , -. 0 + 0
28. AKKUZU, M.; SEZGİN, O.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ALTINTAŞ, E.; ATEŞ, F.; KARA, T.; BERKEŞOĞLU, M. . AKADEMIK GASTROENTEROLOJI DERGISI, 2019, 18, 109-111. 40 + 0
27. AKKUZU, M.; SEZGİN, O.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; KARA, T.; BERKEŞOĞLU, M. . AKADEMIK GASTROENTEROLOJI DERGISI, 2019, 18, 109-111. 20 + 0
2017
26. Altıntaş, E. Gastroözofageal Reflü Hastalığına Farklı Bir Bakış: Özofageal Mikrobiata. GUNCEL GASTROENTEROLOJI, 2017, 21, 287-291. 200 + 0
25. ALTINTAŞ, E. . GUNCEL GASTROENTEROLOJI, 2017, 21, 287-291. 200 + 0
2014
24. Yaraş, S.; Ateş, F.; Sarıtaş, B.; Aydın, M.; Altıntaş, E.; Temel, G.; Sezgin, O. Comparison of endoscopic band ligation treatment patterns (circumferential single row or targeted multi-band) for esophageal variceal hemorrhage. ENDOSKOPI DERGISI, 2014, 22, 1-3. 80 + 0
23. Üçbilek, E.; Doğaner, T.; Koyuncu, M.; Altıntaş, E.; Sezgin, O. Salmonella ileitis that mimicks Crohn’s disease. AKADEMIK GASTROENTEROLOJI DERGISI, 2014, 13, 122-124. 60 + 0
2013
22. Yaraş, S.; Ateş, F.; Sarıtaş, B.; Aydın, M.; Altıntaş, E.; Temel, G.; Sezgin, O. Comparison of results in the short- and long-term treatment of somatostatin infusion for esophageal variceal hemorrhage . ENDOSKOPI DERGISI, 2013, 21, 72-74. 80 + 0
21. Altıntaş, E.; Yaraş, S.; Ateş, F.; Sarıtaş, B.; Sezgin, O.; Orekeci, G. Is there a relationship between ribavirin-induced anemia and viral response rates during HCV therapy?. AKADEMIK GASTROENTEROLOJI DERGISI, 2013, 12, 1-5. 170 + 0
20. Ateş, F.; Yaraş, S.; Sarıtaş, B.; Sezgin, O.; Altıntaş, E. Extensive Intestinal Ischemia After Acute Aortic Dissection. EUROPEAN JOURNAL OF GENERAL MEDICINE, 2013, 10, 47-49. 50 + 0
19. Eser, Z.; Yaraş, S.; Sarıtaş, B.; Ateş, F.; Altıntaş, E.; Serinsöz, E.; Sezgin, O. Colitis due to mycophenolate mofetil after liver transplantation: Case report. AKADEMIK GASTROENTEROLOJI DERGISI, 2013, 12, 74-77. 40 + 0
2012
18. Sezgin, O.; Aydın, M.; Altıntaş, E. Ileoileal intussusception in Meckel’s diverticulum in an adult: The importance of ultrasonography in the diagnosis. AKADEMIK GASTROENTEROLOJI DERGISI, 2012, 11, 29-31. 100 + 0
17. Nayır, E.; Sezgin, O.; Altıntaş, E.; Uçbilek, E. Knowledge levels of general practitioners employed in Mersin province about hepatitis B and hepatitis C. AKADEMIK GASTROENTEROLOJI DERGISI , 2012, 11, 58-6. 150 + 0
2011
16. Köşeci, T.; Karabulut, Ü.; Sarıtaş, B.; Yaraş, S.; Ateş, F.; Altıntaş, E.; Sezgin, O. Ornidazole-induced liver toxicity: Report of two cases. AKADEMIK GASTROENTEROLOJI DERGISI, 2011, 10, 122-124. 30 + 0
15. Ateş, F.; Yaraş, S.; Sarıtaş, B.; Altıntaş, E.; Sezgin, O.; Örekeci, G. Does neutrophil to lymphocyte ratio in peripheral blood predict endoscopic erosive esophagitis?. ENDOSKOPI DERGISI, 2011, 19, 88-90. 110 + 0
14. Ateş, F.; Sarıtaş, B.; Yaraş, S.; Boztepe, B.; Altıntaş, E.; Sezgin, O. A rare cause of lower gastrointestinal bleeding: Rectal varices. ENDOSKOPI DERGISI, 2011, 19, 33-34. 45 + 0
13. Altıntaş, E.; Aslan, G.; Sezgin, O.; Üçbilek, E.; Emekdaş, G.; Gezer, D. Increased serum leptin concentration is related to steatosis in hepatitis C virus-infected patients. AKADEMIK GASTROENTEROLOJI DERGISI, 2011, 10, 97-103. 170 + 0
12. ALTINTAŞ, E.; ASLAN, G.; SEZGİN, O.; ÜÇBİLEK, E.; EMEKDAŞ, G.; gezer, d. . AKADEMIK GASTROENTEROLOJI DERGISI, 2011, 10, 97-103. 170 + 0
11. ALTINTAŞ, E. . AKADEMIK GASTROENTEROLOJI, 2011, 10, 131-134. 200 + 0
10. Altıntaş, E. Hyperhomocysteinemia and liver steatosis: Modification of “the chicken or the egg?” dilemma to the liver. AKADEMIK GASTROENTEROLOJI DERGISI, 2011, 10, 131-134. 200 + 0
2010
9. Altıntaş, E.; Tombak, A.; Tellioğlu, B. The causes, diagnosis and treatment of severe jaundice. AKADEMIK GASTROENTEROLOJI DERGISI, 2010, 9, 2-7. 200 + 0
8. Ateş, F.; Yaraş, S.; Sarıtaş, B.; Altıntaş, E.; Sezgin, O. Endoscopic treatment of acute attacks in chronic pancreatitis in view of two cases. ENDOSKOPI DRGISI, 2010, 18, 32-34. 60 + 0
2008
7. Sezgin, O.; Altıntaş, E.; Tombak, A.; Karabacak, T. A jejunal non-hodgkin’s lymphoma: Initial presentation of celiac disease. AKADEMIK GASTROENTEROLOJI DERGISI, 2008, 7, 46-50. 85 + 0
2003
6. Altıntaş, E.; Tunç, B.; Kacar, S.; Sezgin, O.; Parlak, E.; Altıparmak, E.; Sarıtaş, Ü.; Şahin, B. The efffectiveness of Savary-Gilliard bougie dilatation according to the etyology of benign esophageal strictures. KADEMIK GASTROENTEROLOJI DERGISI, 2003, 2, 15-19. 150 + 0
5. Sayıcı, Y.; Altıntaş, E.; Sezgin, O. Elevated liver enzymes accompanied by gluten enteropathy. AKADEMIK GASTROENTEROLOJI DERGISI,, 2003, 2, 90-92. 100 + 0
4. Oğuz, D.; Altıntaş, E.; Dişibeyaz, S.; Demirbağ, A. s there any beneficial effect of a spasmolytic agent during colonoscopy?. AKADEMIK GASTROENTEROLOJI DERGISI, 2003, 2, 23-27. 170 + 0
2002
3. Pata, C.; Polat, A.; Tiftik, N.; Yazar, A.; Sezer, K.; Bağdatoğlu, Ö.; Kıykım, A.; Altıntaş, E. The level of ICAM-1 and ICAM-3 in liver tissue in patients with chronic hepatitis B. AKADEMIK GASTROENTEROLOJI DERGISI, 2002, 1, 92-96. 20 + 0
2001
2. Altıparmak, E.; Sarıtaş, Ü.; Altıntaş, E.; Türeyen, A.; Oğuz, D.; Şahin, T. Relationship between histological damage, viral load and serum transaminase levels in patients with chronic hepatitis C. TURKISH JOURNAL OF GASTROENTEROLOGY, 2001, 12, 185-188. 130 + 0
1999
1. Altıntaş, E.; Tezel, A. -. GUNCEL GASTROENTEROLOJI, 1999, 3, 66-70. 200 + 0
2019
2. AKKUZU, M.; SEZGİN, O.; YARAŞ, S.; ÖZDOĞAN, O.; YILMAZ, İ.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E. . SISLI ETFAL HASTANESI TIP BULTENI / THE MEDICAL BULLETIN OF SISLI HOSPITAL, 2019, , -. 0 + 0
2013
1. TEZCAN ÜLGER, S.; ÜLGER, M.; ASLAN, G.; YARAŞ, S.; ALTINTAŞ, E.; SEZGİN, O.; EMEKDAŞ, G.; GÜRER, G. . MIKROBIYOLOJI BULTENI, 2013, 47, 332-338. 0 + 0
2021
1. AKKUZU, M.; SEZGİN, O.; ÜÇBİLEK, E.; AYDIN, F.; RIZAOĞLU BALCI, H.; YARAŞ, S.; ÖZDOĞAN, O.; ATEŞ, F.; ALTINTAŞ, E. . MEDICAL BULLETIN OF HASEKI, 2021, 59, -. 10 + 0
2023
2. AYDIN, M.; HARPUT, Z.; ALTINTAŞ, E. . GASTROENTEROHEPATOLOJI, 2023, , 35-41. 100 + 0
1. AYDIN, M.; BAYRAKTAR, O.; ALTINTAŞ, E. . GASTROENTEROHEPATOLOJI, 2023, , 110-117. 100 + 0
1. ALTINTAŞ, E. Endoskopi, ISBN: , falk, Number of print: 1, Total Printing Number: , Page, Turkish, İstambul, Turkey, 2018. 0
1. Altıntaş, E. Ultrasound in Hepatogastroenterology, ISBN: 978-9944-5721-4-9, Fersan Matbaacılık, Number of print: 1, Total Printing Number: 500, 310 Page, Turkish, Ankara, Turkey, 2014. 4500
2. Altıntaş, E. ERCP, ISBN: -, Fersan Matbaacılık, Number of print: 1, Total Printing Number: 500, 350 Page, Turkish, ankara, Turkey, 2013. 8000
3. Altıntaş, E.; Oğuz, P. Gastroenterology, ISBN: 975-93667-2-x, Fersan Matbaacılık, Number of print: 1, Total Printing Number: 300, 889 Page, Turkish, Ankara, Turkey, 2002. 3000
4. Altıntaş, E. Endoskopik Ultrasound, ISBN: 978-9944-5721-6-3, Fersan Matbaacılık, Number of print: 1, Total Printing Number: 500, 403 Page, Turkish, Ankara, Turkey, 2014. 6000
5. Altıntaş, E. Endoscopic ultrasound, ISBN: 978-9944-5721-6-3, TGV Sağlık Mlaz. Ltd.Şti, Number of print: 1, Total Printing Number: 500, 403 Page, Turkish, Ankara, Turkey, 2014. 500
6. Altıntaş, E. ERCP, ISBN: -, Fersan Matbaacılık, Number of print: 1, Total Printing Number: 500, 350 Page, Turkish, Ankara, Turkey, 2013. 8000
7. Altıntaş, E. ERCP, ISBN: -, Fersan Matbaacılık, Number of print: 1, Total Printing Number: 500, 350 Page, Turkish, Ankara, Turkey, 2013. 8000
8. Altıntaş, E. Ultrasound in Hepatogastroenterology, ISBN: 978-9944-5721-4-9, Fersan Matbaacılık, Number of print: 1, Total Printing Number: 500, 310 Page, Turkish, Ankara, Turkey, 2014. 4500
1. BASIR, H.; ALTINTAŞ, E. Tıbbi Terminoloji (Vaka Örnekli), ISBN: 9786253991494, Akademisyen Yayınevi, Number of print: 1, Total Printing Number: , 178 Page, Turkish, Ankara, Turkey, 2024. 0
3. ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O.; ALTINTAŞ, E., Direct-acting antiviral drugs used in the treatment of HCVincrease cholesterol levels. Asian Pacific Association for the Study of the Liver 2019, 2019-02-20, 2019-02-24, Manila, Phillipines, . 80
2. Özdoğan, O.; Yaraş, S.; Üçbilek, E.; Ateş, F.; Sezgin, O.; Altıntaş, E., Direct-acting antiviral drugs used in the treatment of HCV increase cholesterol levels.. The Asian Pacific Association for the Study of the Liver (APASL), 2019-02-20, 2019-02-24, Manila, Phillipines, 2019. 80
1. YARAŞ, S.; ÜÇBİLEK, E.; Yılmaz, İ.; ÖZDOĞAN, O.; ALTINTAŞ, E.; SEZGİN, O., The real-life experience with directly acting antivirals in chronichepatitis C treatment: a single center experience from Turkey. APASL 2018, 2018-03-14, 2018-03-18, , , . 90
17. AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; BERKEŞOĞLU, M., 271 Examination of splenectomy patient, can the gaucher disease be the cause of splenomegaly in patients with splenectomy?. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, İSTANBUL, Turkey, . 25
16. AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., Retrospective evaluation of corrosive agents: Single center experience. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, İSTANBUL, Turkey, . 30
15. AYKUT, A.; RIZAOĞLU BALCI, H.; AYDIN, F.; AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E., Inapproprıate prescrıptıon of oral proton pump ınhıbıtors ın patıents wıth acute pancreatıtıs: a retrospectıve cross-sectıonal study. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, İSTANBUL, Turkey, . 10
14. AKKUZU, M.; RIZAOĞLU BALCI, H.; AYDIN, F.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F., Controlling nutritional status (CONUT) score is a prognostic marker for acute pancreatitis. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, İSTANBUL, Turkey, . 10
13. AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., Investigation of column polyp properties, single center experience. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, İSTANBUL, Turkey, . 30
12. AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., Localization of gastric polyps, histopathologic features and evaluation of the relationship with helicobakter pylori single center experience. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, İSTANBUL, Turkey, . 30
11. ALTINTAŞ, Z.; TUĞ BOZDOĞAN, S.; ALTINTAŞ, E., LDLR gene exon 12 RS 688 polymorphism causes to increase in susceptibility tohepatitis C. Proceedings of the World Congress of Gastroenterology, 2019-09-21, 2019-09-24, İSTANBUL, Turkey, . 100
10. AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., Foreign bodies on the path of nutrition retrospective evaluation of our clinical experience. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, İSTANBUL, Turkey, . 30
9. AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; RIZAOĞLU BALCI, H.; AYDIN, F., EUS accuracy against MRCP for detection of pancreaticobiliary lesions. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, İstanbul, Turkey, . 10
8. ATEŞ, F.; KÖSE, A.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ALTINTAŞ, E.; SEZGİN, O., The role of hematological parameters in determining the severity and prognosis of acute pancreatitis. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, İSTANBUL, Turkey, . 15
7. AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., Stenting in digestive system stenosis: Single center experience. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, İSTANBUL, Turkey, . 30
6. AKKUZU, M.; SEZGİN, O.; BOZKURT BABUŞ, S.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ALTINTAŞ, E., Wild mushroom poisoning in Mersin: A retrospective epidemiological study and investigation of liver toxicity. AASLD-TASL CONNECT REGİONAL MEETİNG, 2019-03-15, 2019-03-16, İstanbul, Turkey, . 20
5. AKKUZU, M.; SEZGİN, O.; YARAŞ, S.; ALTINTAŞ, E., Evaluation of Anti-HCV positive HCV-RNA negative patients: İs it a safe condition ?. AASLD-TASL CONNECT REGİONAL MEETİNG, 2019-03-15, 2019-03-16, İstanbul, Turkey, . 65
4. ALTINTAŞ, E.; SEZGİN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ÖZDOĞAN, O.; YARAŞ, S.; YILMAZ, İ., TITLE: THE ROLE OF INTRAVENOUS HYDRATION WITH LACTATED RINGER'S SOLUTION IN PREVENTING POST-ERCP PANCREATITIS. DDW2018, 2018-06-02, 2018-06-06, Washington, United States of America, 2018. 75
3. ALTINTAŞ, Z.; YILMAZ, İ.; ÇELİK, H.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O.; ATEŞ, F., The Influence Of MTHFR Gene Polymorphism On The Long Term Course In G1 Hepatitis C Patients Who Are Achieved Sustained Viral Response With Treated With Pegylated Interferon Plus Ribavirin.. APASL, 2018-03-14, 2018-03-18, Yeni Delhi, India, 2018. 10
2. ALTINTAŞ, E.; YARAS, S.; AYDIN, M.; KOYUNCU, M.; ÇİMEN, M.; ÜÇBİLEK, E.; ATEŞ, F., serum chitotriosidase levels in malignant diseases of liver: is it a new tumor marker?. 25th Asian Pacific Association for the Study of the Liver, 2016-02-20, 2016-02-24, Tokyo, Japan, 2016. 75
1. ALTINTAŞ, E., Serum Chitotriosidase Levels In Malignant Diseases Of Liver: Is It A New Tumor Marker?. Falk Symposium 199, 2015-10-14, 2015-10-17, Freiburg, Germany, 2015. 100
7. ALTINTAŞ, E., Oral ritlecitinib and brepocitinib in patients with Moderate to Severe Active Ulcerative Colitis: Data from the VIBRATO umbrella study. 16. ECCO, 2021-07-02, , , England / United Kingdom, . 100
6. ALTINTAŞ, E., Pankreatosteatozun Klinik Önemi. 18. Ulusal Hepato Gastroenteroloji Kongresi, 2022-05-12, 2022-05-15, BAFRA, TRNC, 2022. 100
5. ALTINTAŞ, Z.; ALTINTAŞ, E., The side effects of direct acting antivirals in hepatitis c patientsare associated with oatp 334 T [G variant. 29th Annual Conference of Asian Pacific Association for the Study of the Liver, 2020-03-04, 2020-03-08, , , . 100
4. YARAŞ, S.; ÜÇBİLEK, E.; YILMAZ, İ.; ÖZDOĞAN, O.; ALTINTAŞ, E.; SEZGİN, O., The real-life experience with directly acting antivirals in chronichepatitis C treatment: a single center experience from Turkey. 27th Annual Conference of APASL,March 14–18, 2018, New Delhi, India, 2018-03-14, 2018-03-18, , , . 45
3. YARAŞ, S.; SEZGİN, O.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; ALTINTAŞ, E., Mo1404 - Does Sustained Viral Response Achieved with Direct Acting Antiviral Drugs Correlate with the Liver Shear Wave Elastography Changes and Liver Fibrosis in Chronic HCV Patients?. aasld, 2018-01-12, 2018-01-15, , , . 50
2. Taş, E.; Kurt, S.; Özdoğan, O.; Yaraş, S.; Üçbilek, E.; Ateş, F.; Sezgin, O., Is There A Relationship Between The Peripheral Platelet Count And Tumor Size In Hepatocellular Carcinoma?. 7th international gastrointestinal cancers conference, 2017-12-01, 2017-12-06, İstanbul, Turkey, 2017. 10
1. ALTINTAŞ, E.; SEZGİN, O.; Öksüz, Z.; GÜRER GİRAY, B.; ALTINTAŞ, E.; TİFTİK, E.; DÖĞEN, A., Biomarker Potential of Several miRNAs For The Early Diagnosis of Hepatocellular Carcinoma Related With HBV and HCV Infections. Global Biotechnology Congress 2017, 2017-07-10, 2017-07-13, Boston, United States of America, . 65
51. ALTINTAŞ, E., e. anthem uc investigator meeting, 2024-01-19, 2024-01-20, Roma, Italy, 2024. 50
50. ALTINTAŞ, E., e. anthem uc investigator meeting, 2024-01-19, 2024-01-20, Roma, Italy, 2024. 50
49. ALTINTAŞ, E., GALAXI & GRAVITI Investigator Meetings. GALAXI & GRAVITI Meetings, 2022-09-09, 2022-09-09, Munich, Germany, 2022. 50
48. ALTINTAŞ, E., CULTIVATE EMEA Investigators' Meeting.. CULTIVATE EMEA Investigators' Meeting., 2022-09-01, 2022-09-02, Viyana, Austria, 2022. 50
47. ALTINTAŞ, E., Gerçek Yaşam Verileri ışığında ETV Hasta Deneyimi. Chronic Hepatitis Single Topic Conference, 2021-10-23, 2021-10-24, Magosa, TRNC, 2021. 50
46. AYDIN, F.; RIZAOĞLU BALCI, H.; AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F., The role of eLIFT score as a Non- invasive Method in Determining the level of Liver Fibrosis in Turkish Hepatitis B Patients. Asian Pacific Association for the Study of the Liver, 2020-03-04, 2020-03-08, Bali, Indonesia, . 5
45. AYDIN, F.; RIZAOĞLU BALCI, H.; AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F., A Rare Liver Malignancy :Angiosarcoma. Asian Pacific Association for the Study of the Liver, 2020-03-04, 2020-03-08, Bali, Indonesia, . 5
44. AYDIN, F.; RIZAOĞLU BALCI, H.; AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F., The role of eLIFT score as a non-invasive method in determiningthe level of liver fibrosis in Turkish hepatitis B patients. 9th Annual Conference of Asian Pacific Association for the Study of the Liver, 2020-03-04, 2020-03-06, Bali, Indonesia, . 5
43. ALTINTAŞ, Z.; ALTINTAŞ, E., The association between OATP variants and hepatocellularcancer risk in hepatitis C patients who treated with direct actingantivirals. 29th Annual Conference of Asian Pacific Association for the Study of the Liver, 2020-03-04, 2020-03-06, Bali, Indonesia, . 50
42. SEZGİN, O.; boztepe, b.; ALTINTAŞ, E.; çelikcan, d., Irritable bowel syndrome in inflammatory bowel disease after remission: correlation with remission patterns and inflammation. ECCO Congress, 2020-02-12, 2020-02-15, viyana, Austria, . 37
41. ALTINTAŞ, E.; SEZGİN, O.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; ATEŞ, F.; YARAŞ, S.; YILMAZ, İ., THE ROLE OF INTRAVENOUS HYDRATION WITH LACTATED RINGER’xxS SOLUTION IN PREVENTING POST-ERCP PANCREATITIS. AGA congress, 2019-11-17, 2019-11-20, , , . 37
40. AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., Stenting in digestive system stenosis: Single center experienc. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, istanbul, Turkey, . 15
39. AYKUT, A.; RIZAOĞLU BALCI, H.; AYDIN, F.; AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E., Inapproprıate prescrıptıon of oral proton pump ınhıbıtors ın patıents wıth acute pancreatıtıs: a retrospectıve cross-sectıonal study. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, istanbul, Turkey, . 5
38. AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., Foreign bodies on the path of nutrition retrospectiv evaluation of our clinical experience. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, istanbul, Turkey, . 15
37. AKKUZU, M.; RIZAOĞLU BALCI, H.; AYDIN, F.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F., Controlling nutritional status (CONUT) score is a prognostic marker for acut pancreatitis. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, istanbul, Turkey, . 5
36. AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., Retrospective evaluation of corrosive agent: Single center experience. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, istanbul, Turkey, . 15
35. AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., Investigation of column polyp properties, single center experienc. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-21, istanbul, Turkey, . 15
34. ATEŞ, F.; KÖSE, A.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; SEZGİN, O.; ALTINTAŞ, E., The role of hematological parameters in determining the severity and prognosis of acut pancreatitis. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, istanbul, Turkey, . 5
33. AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; BERKEŞOĞLU, M., 271 Examination of Splenectomy Patient, Can The Gaucher Disease be the Cause of Splenomegaly in Patients with Splenectomy. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, istanbul, Turkey, . 12
32. AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; RIZAOĞLU BALCI, H.; AYDIN, F., EUS accuracy against MRCP for detection of pancreaticobiliary lesions. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, İstanbul, Turkey, . 5
31. AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., Localization of gastric polyps, histopathologic features and evaluation of the relationship with helicobakter pylori single center experience. World Congress of Gastroenterology (WCOG), 2019-09-21, 2019-09-24, istanbul, Turkey, . 15
30. AKKUZU, M.; SEZGİN, O.; BOZKURT BABUŞ, S.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ALTINTAŞ, E., Wild mushroom poisoning in Mersin: A retrospective epidemiological study and investigation of liver toxicity. AASLD - TASL CONNECT REGIONAL MEETING, 2019-03-15, 2019-03-16, istanbul, Turkey, . 10
29. YARAŞ, S.; SEZGİN, O.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; ALTINTAŞ, E., DOES SUSTAINED VIRAL RESPONSE ACHIEVED WITH DIRECT ACTING ANTIVIRAL DRUGS CORRELATE WITH THE LIVER SHEAR WAVE ELASTOGRAPHY CHANGES AND LIVER FIBROSIS IN CHRONIC HCVPATIENTS?. Congress of AASLD (American Association for the Study of Liver Diseases ), 2018-11-09, 2018-11-13, San Francisco, United States of America, . 25
28. rastgeldi, a.; YILMAZ, İ.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O., The long term effect of entecavir and tenofovir on lipid measurements in chronic hepatits B. Global Hepatitis Summit, 2018-06-14, 2018-06-17, toronto, Canada, . 5
27. ALTINTAŞ, E.; SEZGİN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ÖZDOĞAN, O.; YARAŞ, S.; YILMAZ, İ., THE ROLE OF INTRAVENOUS HYDRATION WITH LACTATED RINGER’xxS SOLUTION IN PREVENTINGPOST-ERCP PANCREATITIS. DDW2018, 2018-06-02, 2018-06-06, wASHİNGTON, United States of America, . 37
26. Yaraş, S.; Üçbilek, E.; Yılmaz, İ.; Özdoğan, O.; Altıntaş, E.; Sezgin, O., The real-life experience with directly acting antivirals in chronic hepatitis C treatment: a single center experience from Turkey. APASl 2018, 2018-03-14, 2018-03-18, Delhi, India, 2018. 22
25. ALTINTAŞ, E.; ALTINTAŞ, Z.; YILMAZ, İ.; ÇELİK, H.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O., The Influence Of MTHFR Gene Polymorphism On The LongTerm Course In G1 Hepatitis C Patients Who Are AchievedSustained Viral Response With Treated With PegylatedInterferon Plus Ribavirin.. 27th Annual Conference of APASL, 2018-03-14, 2018-03-18, YENİ DELHİ, India, . 35
24. YARAŞ, S.; ÜÇBİLEK, E.; YILMAZ, İ.; ÖZDOĞAN, O.; ALTINTAŞ, E.; SEZGİN, O., The real-life experience with directly acting antivirals in chronichepatitis C treatment: a single center experience from Turkey. APASL2018, 2018-03-14, 2018-03-18, Delhi, India, . 22
23. ALTINTAŞ, E.; ALTINTAŞ, Z.; YILMAZ, İ.; ÇELİK, H.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O., The Influence Of MTHFR Gene Polymorphism On The LongTerm Course In G1 Hepatitis C Patients Who Are AchievedSustained Viral Response With Treated With PegylatedInterferon Plus Ribavirin.. APASl 2018, 2018-03-14, 2018-03-18, Delhi, , . 35
22. ATEŞ, F.; DEMİR, M.; ALTINTAŞ, E.; SEZGİN, O., Efficacy and safety of budesonide as a maintenance therapyfor patients with autoimmune hepatitis. APASL 2018, 2018-03-14, 2018-03-18, Delhi, India, . 37
21. ALTINTAŞ, E.; ALTINTAŞ, Z.; yılmaz, i.; ÇELİK, H.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O., The Influence Of MTHFR Gene Polymorphism On The Long Term Course In G1 Hepatitis C Patients Who Are Achieved Sustained Viral Response With Treated With Pegylated Interferon Plus Ribavirin. 27th Annual Conference of APASL, 2018-03-14, 2018-03-18, Yeni Delhi, India, . 35
20. Ateş, F.; Demir, M.; Altıntaş, E.; Sezgin, O., Efficacy and safety of budesonide as a maintenance therapy for patients with autoimmune hepatitis. APASL 2018, 2018-03-14, 2018-03-18, Delhi, India, 2018. 37
19. ÜÇBİLEK, E.; YARAŞ, S.; SARITAŞ, B.; AYDIN, M.; SEZGİN, O.; ATEŞ, F.; OREKİCİ TEMEL, G., What is the risk of malignancy at normal appearing mucosa in left-side ulcerative colitis ?. 7th International Gastrointestinal Cancer Conference, 2017-12-15, 2017-12-17, , , . 5
18. Alakuş, C.; Göbel, S.; Yaraş, S.; Özdoğan, O.; Üçbilek, E.; Ateş, F.; Sezgin, O., A new scoring method in hepatocell ular carcinoma : Is there a relation between ''Agresiveness Index '' and survival ?. 7th international gastrointestinal cancers conference, 2017-12-15, 2017-12-17, İstanbul, Turkey, 2017. 5
17. Üçbilek, E.; Yaraş, S.; Sarıtaş, B.; Aydın, M.; Sezgin, O.; Ateş, F.; Örekeci Temel, G., What is the risk of malignancy at normal appearing mucosa in left-side ulcerative colitis ? . 7th international gastrointestinal cancers conference, 2017-12-15, 2017-12-17, İstanbul, Turkey, 2017. 5
16. ALAKUŞ, S.; GÖBEL, S.; YARAŞ, S.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; ATEŞ, F.; SEZGİN, O., A New Scoring Method in Hepatocellular Carcinoma: Is There a Relation Between ”Agresiveness Index” and Survival. 7th International Gastrointestinal Cancer Conference, 2017-12-15, 2017-12-17, , , . 5
15. ALTINTAŞ, E.; KOYUNCU, M.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O., PROGNOSTIC ABILITY OFINFLAMMATION BASED SCORES INACUTE PANCREATITIS.. 12th Biennial Congress of the European-African Hepator-Pancreato-Biliary Association (E-AHPBA), 2017-05-23, 2017-05-26, , , . 42
14. Altıntaş, E.; Bakır Koyuncu, M.; Yaraş, S.; Uçbilek, E.; Ateş, F.; Sezgin, O., Prognostic Ability Of Inflammation Based Scores In Acute Pancreatitis. 12th International Congress of the European-African Hepato-Pancreato-Biliary Association , 2017-05-23, 2017-05-26, Mainz, Germany, 2017. 42
13. ALTINTAŞ, E.; KOYUNCU, M.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O., Prognostic Ability Of Inflammation Based Scores In Acute Pancreatitis. 12th Biennial E-AHPBA Congress, 2017-05-23, 2017-05-26, , , . 42
12. ALTINTAŞ, E.; YARAŞ, S.; OREKİCİ TEMEL, G., The relationship between the serum chitotriodase level and the liver fibrosis in patients with hepatocellular carcinoma. 26th Annual Conference of APASL, 2017-02-15, 2017-02-19, , , . 50
11. Altıntaş, E.; Ayaz, L.; Sezgin, O.; Üçbilek, E.; Tamer, L.; Tombak, A., Hepatic steatosis and fibrosis in patients with chronic hepatitis C: the effect of S-adenosylhomocysteine. 26. APASL 2017, 2017-02-15, 2017-02-19, Şangay, China, 2017. 42
10. Ateş, F.; Coşkun, Ü.; Sezgin, O.; Altıntaş, E., The importance of MTHFR A1298C and C677T gene polymorphisms in non-obese NASH patients. 25. APASL, 2016-02-20, 2016-02-24, Tokyo, Japan, 2016. 32
9. Oguz, D.; Altintas, E.; Ucbilek, E.; Ates, F.; Sezgin, O., Endoscopic ultrasound elastography for differantiation of benign and malign pancreatic lesions. e-p-c 2015, 2015-06-24, 2015-06-26, Toledo, Spain, 2015. 40
8. Oguz, D.; Sezgin, O.; Altintas, E.; Ucbilek, E.; Ates, F., Predictive factors for post-ERCP pancreatitis: A tertiary referal center study. e-p-c 2015, 2015-06-24, 2015-06-26, Toledo, Spain, 2015. 35
7. Altintas, Z.; Ucbilek, E.; Erdal, M.; Sezgin, O.; Altintas, E., Mo1721 Methylation and Expression of the Genes That Have a Role in the Wnt Signaling Pathway in Ulcerative Colitis. DDW 2015, 2015-05-16, 2015-05-19, Washington, United States of America, 2015. 25
6. Sezgin, O.; Altintas, E.; Ucbilek, E.; Ates, F.; Yaras, S.; Ates, B.; Aydın, M., P1278 : Effects of “chronic hepatitis patients information and morale meetings” on patient compliance and treatment success. EASL 2015, 2015-04-22, 2015-04-26, Viyana, Austria, 2015. 35
5. Boztepe, B.; Sezgin, O.; Altintas, E.; Ovla, D., P176 Irritable bowel syndrome frequency in Inflammatory Bowel Disease during both clinical and deep remission and its association with fecal calprotectin. ECCO 2015, 2015-02-18, 2015-02-21, Barselona, Spain, 2015. 37
4. Sezgin, O.; Boztepe, B.; Altintas, E.; Kanik, A.; Ovla, D., P283 Effectiviness of fecal calprotectin measurement determining deep remission in Inflammatory Bowel Disease. ECCO 2015, 2015-02-18, 2015-02-21, Barselona, Spain, 2015. 35
3. Altıntas, E.; Yaras, S.; Ates, F.; Saritas, B.; Aydın, M.; Sezgin, O., P648 What is the risk of malignancy at normal appearing mucosa in left-side ulcerative colitis patients?. ECCO 2014, 2014-09-20, 2014-09-22, Kopenhag, Denmark, 2014. 42
2. Karabulut, U.; Koyuncu, M.; Sezgin, O.; Ucbilek, E.; Aydin, M.; Altintas, E., Mo1327 Early Oral Feeding and Selection of Initial Diet in Mild Acute Pancreatitis. DDW 2014, 2014-05-03, 2014-05-06, Şikago, United States of America, 2014. 20
1. Ucbilek, E.; Sezgin, O.; Altintas, E., Su1907 Low Dose Bolus Pantoprazole Following Succesful Endoscopic Treatment for Acute Peptic Ulcer Bleeding Is Effective: A Randomised, Prospective, Double-Blind, Double Dummy Pilot Study. DDW 2013, 2013-05-18, 2013-05-21, Orlando, United States of America, 2013. 50
7. ALTINTAŞ, E., Yoğun Bakım Hastasında Nutrisyonel Durumun Değerlendirilmesi. UGH 223, 2023-11-22, 2023-11-25, Antalya, Turkey, 2023. 100
6. AYDIN, F.; RIZAOĞLU BALCI, H.; AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F., Türk Hepatit B Hastalarında KaraciğerFibroz Düzeyinin Tespitinde Non İnvazivYöntem Olarak eLİFT Skorunun Yeri. 36.UGH MEZUNİYET SONRASI EĞİTİM TOPLANTISI VE 7. GASTROENTEROLOJİ CERRAHİSİ KONGRESİ, 2019-11-29, 2019-12-01, Antalya, Turkey, . 10
5. AYDIN, F.; RIZAOĞLU BALCI, H.; AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F., Türk Hepatit B Hastalarında Karaciğer Fibroz Düzeyinin Tespitinde Non İnvaziv Yöntem Olarak ELİFT Skorunun Yeri. 36.UGH 2019 Mezuniyet Sonrası Eğitim Toplantısı ve 7. Ulusal Gastroenteroloji Cerrahisi Kongresi, 2019-11-29, 2019-12-01, ANTALYA, Turkey, . 10
4. AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; YILMAZ, İ.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O., Anti HCV Pozitif Saptanıp Takip ve Tedavisiz Kalmış Hastalar: Farkındalığın Arttırılması Gerekli. 35.Ulusal Gastroenteroloji Haftası, 2018-11-21, 2018-11-25, Antalya, Turkey, . 10
3. İşgüzar, E.; Üçbilek, E.; Yaraş, S.; Özdoğan, O.; Yılmaz, İ.; Ateş, F.; Sezgin, O., ERCP SONRASI GELİŞEN PANKREATİTİN ÖNLENMESİNDE İNTRAVENÖZ HİDRASYONUN ROLÜ. 34.ULUSAL GASTROENTEROLOJI . HAFTASI, 2017-12-01, 2017-12-06, Antalya, Turkey, 2017. 10
2. ALTINTAŞ, E., Rezistans ile ilişkili varyantlar; tedavide ne kadar sorun oluşturacak?. 14. Doğu ve Güneydoğu Anadolu Gastroenteroloji Okulu, 2016-09-30, 2016-10-01, Hatay, Turkey, 2016. 100
1. ALTINTAŞ, E., Karaciğer Ultrasonografisi. 12. Ulusal Hepato Gastroenteroloji Kongresi ve 3. Ulusal Gastroenteroloji Cerrahisi Kongresi, 2015-10-07, 2015-10-11, AFYON, Turkey, 2015. 100
15. ŞEN, Ş.; AKKUZU, M.; YARAŞ, S.; SEZGİN, O.; YILMAZ, İ.; ÖZDOĞAN, O.; ÜÇBİLEK, E., Karaciğer Sirozunda Portal Veni Tamamen Tıkamış Yaygın Trombüs Olgusu. 12. Ulusal Hepatoloji Kongresi, 2019-05-01, 2019-05-05, , Turkey, . 5
14. AKKUZU, M.; SEZGİN, O.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E., Koroziv madde alımlarının değerlendirilmesi: Tek merkez deneyimi. 5. GASTROİNTESTİNAL ENDOSKOPİ GÜNLERİ, 2019-04-12, 2019-04-13, , Turkey, . 10
13. AKKUZU, M.; SEZGİN, O.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E., Beslenme Yolundaki Yabancı Cisimler Klinik deneyimimizin retrospektif olarak değerlendirilmesi. 5. GASTROİNTESTİNAL ENDOSKOPİ GÜNLERİ, 2019-04-12, 2019-04-13, , Turkey, . 10
12. ÜÇBİLEK, E.; ŞAHİN HORASAN, E.; YARAŞ, S.; ÖZDOĞAN, O.; ATEŞ, F.; RIZAOĞLU BALCI, H.; ALTINTAŞ, E., Damar İçi Madde Bağımlılarında Hepatit C Tedavisi: Gerçek Yaşam Verileri. 35. Ulusal Gastroenteroloji Haftası, 2018-11-21, 2018-11-25, Antalya, Turkey, . 8
11. ÖZDOĞAN, O.; YARAŞ, S.; YILMAZ, İ.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O.; ALTINTAŞ, E., Mastektomiden 6 yıl sonra tam pilor darlığı şeklinde nüks eden meme karsinom vakası. 35. Ulusal Gastroenteroloji Haftası, 2018-11-21, 2018-11-25, Antalya, Turkey, . 10
10. ALTINTAŞ, Z.; YILMAZ, İ.; ÇELİK, H.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O.; ATEŞ, F., PEGILE İNTERFERON PLUS RIBAVIRIN TEDAVISI İLE KALICIVIRAL YANIT GERÇEKLEŞEN G1 HEPATIT C HASTALARINDAMTHFR GEN POLIMÖRFIZMININ UZUN VADEDE ETKILERI. 34. Ulusal gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 5
9. YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., KRONIK HEPATIT C TEDAVISINDE DIREKT ETKILIANTIVIRALLERLE TEDAVI DENEYIMIMIZ, 1. YIL SONUÇLARI. 34. Ulusal Gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 22
8. ÜÇBİLEK, E.; YARAŞ, S.; SEZGİN, O.; ALTINTAŞ, E.; ATEŞ, F.; ÖZDOĞAN, O., KRONIK HEPATIT C’LI KRONIK BÖBREK YETMEZLIĞIHASTALARINDA ROP-D TEDAVI SONUÇLARIMIZ- TEK MERKEZ DENEYIMI. 34. Ulusal gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 27
7. ÖZDOĞAN, O.; YARAŞ, S.; YILMAZ, İ.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O.; ALTINTAŞ, E., İLIOÇEKAL INVAJINASYON ILE PREZENTE OLAN NON-HODGKIN LENFOMA. 34. Ulusal gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 10
6. RASTGELDİ, A.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O.; YILMAZ, İ.; ATEŞ, F.; SEZGİN, O., KRONIK HEPATIT B HASTALARINDA TENOFOVIR VEENTEKAVIR’IN ETKINLIK VE GÜVENILIRLIĞININ İNVAZIVOLMAYAN YÖNTEMLERLE DEĞERLENDIRILMESI. 34.Ulusal Gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 5
5. RASTGELDİ, A.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O.; YILMAZ, İ.; ATEŞ, F.; SEZGİN, O., KRONIK HEPATIT B HASTALARINDA TENOFOVIR VEENTEKAVIR’IN LIPID ÖLÇÜTLERINE UZUN DÖNEMDE ETKISI. 34.Ulusal gastroneteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 5
4. ÖZDOĞAN, O.; YARAŞ, S.; YILMAZ, İ.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O.; ALTINTAŞ, E., YABANCI CISIM DIREKT GRAFI YANILTICI OLABILIR MI ?. 34. Ulusal Gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 10
3. ALAKUŞ, S.; GÖBEL, S.; YARAŞ, S.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; ATEŞ, F.; SEZGİN, O., HEPATOSELLÜLER KANSER HASTALARINDA YENI BIRSKORLAMA YÖNTEMI: ‘’AGRESIVENESS INDEX’’ ILE SAĞKALIM ARASINDA ILIŞKI VAR MI? - TEK MERKEZ SONUÇLARI. 34. Ulusal Gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 5
2. TAŞ, E.; KURT, S.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O., HEPATOSELLÜLER KANSERDE PERIFERIK KANDA TROMBOSIT SAYISI ILE TÜMÖR BOYUTU ARASINDA ILIŞKI VAR MI?. 34. Ulusal Gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 5
1. KURT, S.; TAŞ, E.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O., AKUT PANKREATITTE SERUM KALSIYUM DÜZEYINDEKI GÜNLÜK DEĞIŞIMLER PROGNOZ ÜZERINDE ETKILI MIDIR?. 34. Ulusal Gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 5
1. ALTINTAŞ, E., Ödematöz Pankreatİt Erken Evre KomplİkasyonlarIn Yönetİmİ. ULUSAL GASTROENTEROLOJİ HAFTASI, 2020-11-25, 2020-11-29, , Turkey, . 0
14. RIZAOĞLU BALCI, H.; ALTINTAŞ, E.; ATEŞ, F.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O.; AKKUZU, M., İNTESTİNAL LENFANJİEKTAZİ İLE PREZENTE OLANWALDESTROM MAKROGLOBULİNEMİ OLGUSU. 37. Ulusal Gastroenteroloji Kongresi ve8. Ulusal Gastroenteroloji Cerrahisi Kongresi, 2020-11-25, 2020-11-29, , Turkey, . 30
13. AYDIN, F.; AKKUZU, M.; RIZAOĞLU BALCI, H.; SEZGİN, O.; ALTINTAŞ, E.; ATEŞ, F.; ÜÇBİLEK, E., Nadir Bir Karaciğer Malignitesi: Anjiosarkom. 16. Anadolu Gastroenteroloji Günleri, 2020-09-11, 2020-09-12, Şanlıurfa, Turkey, . 15
12. ALTINTAŞ, E., Rutin Endoskopide Neler Yapılmalı, Neler Yeterlidir. “5. Gastrointestinal Endoskopi Günleri, 2019-04-13, 2019-04-13, İstanbul, Turkey, 2019. 50
11. ALTINTAŞ, E., Rutin Endoskopide Neler Yapılmalı, Neler Yeterlidir. “5. Gastrointestinal Endoskopi Günleri, 2019-04-13, 2019-04-13, İstanbul, Turkey, 2019. 50
10. ATEŞ, F.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ALTINTAŞ, E.; SEZGİN, O., Can Budesonide be a new standard of remission maintenance therapy for non-cirrhotic patients with AIH?. GERÇEK YAŞAMDA KARACİĞER VEİNFLAMATUAR BARSAK HASTALIĞISEMPOZYUMU, 2019-03-22, 2019-03-23, Hatay, Turkey, . 22
9. ATEŞ, F.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ALTINTAŞ, E.; SEZGİN, O., İnflamatuvar barsak hastalarında Adalimumab etkinliği. GERÇEK YAŞAMDA KARACİĞER VEİNFLAMATUAR BARSAK HASTALIĞI SEMPOZYUMU, 2019-03-22, 2019-03-23, Hatay, Turkey, . 22
8. AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; SEZGİN, O., Anti HCV Pozitif Saptanıp Takip ve Tedavisiz Kalmış Hastalar: Farkındalığın Arttırılması Gerekli.. 35. Ulusal Gastroenteroloji Haftası, 2018-11-21, 2018-11-25, antalya, Turkey, . 12
7. ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; SEZGİN, O.; ALTINTAŞ, E., HCV tedavisinde kullanılan doğrudan etikili antiviral ilaçların insülin direnci ve lipid parametreleri üzerine etkileri. 35. ULUSAL GASTROENTEROLOJİ HAFTASI, 2018-11-21, 2018-11-25, Antalya, Turkey, . 20
6. YARAŞ, S.; SEZGİN, O.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; ALTINTAŞ, E.; ATEŞ, F., KRONIK HCV HASTALARINDA DIREKT ETKILI ANTIVIRALILAÇLARLA KALICI VIRAL YANIT FIBROZISE OLUMLU YANSIYOR MU? (SHEAR WAVE ELASTOGRAFIYLE ERKEN DÖNEM SONUÇLARIMIZ). 34.Ulusal Gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 22
5. Yaraş, S.; Sezgin, O.; Üçbilek, E.; Özdoğan, O.; Ateş, F.; Altıntaş, E., KRONIK HCV HASTALARINDA DIREKT ETKILI ANTIVIRAL ILAÇLARLA KALICI VIRAL YANIT FIBROZISE OLUMLU YANSIYOR MU? (SHEAR WAVE ELASTOGRAFIYLE ERKEN DÖNEM SONUÇLARIMIZ. 34. Ulusal Gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, 2017. 20
4. KIRMIZIER, G.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O.; YILMAZ, İ.; ATEŞ, F.; SEZGİN, O., ERCP SONRASI GELIŞEN PANKREATITIN ÖNLENMESINDEİNTRAVENÖZ HIDRASYONUN ROLÜ. 34. Ulusal Gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, . 5
3. ALTINTAŞ, E., Pankreasın ve Biliyer Sistemin Ultrasonografik Değerlendirilmesi. 13. Ulusal Hepato Gastroenteroloji Kongresi, 15. Avrasya Gastroenteroloji Kongresi ve 4. Ulusal Gastroenteroloji Cerrahisi Kongresi, 2016-04-27, 2016-05-01, Antalya, Turkey, 2016. 50
2. ALTINTAŞ, E., Kolonoskopik Snear Polipektomide Dikkat Edilecekler. İNTESTİNAL HASTALIKLAR VE CERRAHİSİ, 2016-03-18, 2016-03-20, Adana, Turkey, 2016. 50
1. ALTINTAŞ, E., Karaciğer Ultrasonografisi. 12.Ulusal Hepato Gastroenteroloji Kongresi ve 3.Ulusal Gastroenteroloji Cerrahisi Kongresi, 2015-10-07, 2015-10-11, Afyon, Turkey, 2015. 50
25. ALTINTAŞ, E., Akut Pankreatitte Nütrisyon. TGD Okulları Çanakkale -Gastroenteroloji ve Nütrisyon: İhmal Edilmemesi Gerekenler., 2023-10-20, 2023-10-22, Çanakkale, Turkey, 2023. 25
24. ALTINTAŞ, E., Toksik Hepatit Oturumu. 14. Ulusal Hepatoloji Kongresi, 2023-05-17, 2023-05-21, Antalya, Turkey, 2023. 25
23. ALTINTAŞ, E., Fonksiyonel Diyare Kılavuzu (ESNM) 2022,. 4. Gazi Gastroenteroloji Günleri, 2023-02-24, 2023-02-25, Ankara, Turkey, 2023. 25
22. ALTINTAŞ, E., Hepatoselüler Karsinom Kursu. Ulusal Gastroenteroloji Haftamız, 2022-11-22, 2022-11-27, Antalya, Turkey, 2022. 25
21. ALTINTAŞ, E., Sistemik Tedavi: Monoklonal Antikorlardan Beklentilerimiz. Ulusal Gastroenteroloji Haftas, 2021-11-16, 2021-11-21, Antalya, Turkey, 2021. 25
20. AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; AYDIN, F., DEMİR EKSİKLİĞİ ANEMİSİ NEDENİYLE ENDOSKOPİVE KOLONOSKOPİ YAPILAN HASTALARDAMALİGNİTE SIKLIĞININ DEĞERLENDİRİLMESİ. 37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi, 2020-11-25, 2020-11-29, , Turkey, . 5
19. AKKUZU, M.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; YARAŞ, S.; ATEŞ, F.; ALTINTAŞ, E.; RIZAOĞLU BALCI, H., GAİTADA GİZLİ KAN POZİTİFLİĞİ NEDENİYLEKOLONOSKOPİ YAPILANLARDA KOLOREKTALMALİGNİTE SIKLIĞI. 37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi, 2020-11-25, 2020-11-29, , Turkey, . 5
18. AKKUZU, M.; YARAŞ, S.; ÜÇBİLEK, E.; ÖZDOĞAN, O.; ATEŞ, F.; ALTINTAŞ, E.; AYDIN, F., TÜM ÖZELLİKLERİ İLE KOLON POLİPLERİ: DOĞUAKDENİZDE ÜÇÜNCÜ BASAMAK MERKEZDENEYİMİ. 37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi, 2020-11-25, 2020-11-29, , Turkey, . 5
17. AKKUZU, M.; ÖZDOĞAN, O.; YARAŞ, S.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; RIZAOĞLU BALCI, H., GASTRİK POLİPLER: DOĞU AKDENİZDE 3.BASAMAK GASTROENTEROLOJİ MERKEZİSONUÇLARI. 37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi, 2020-11-25, 2020-11-29, , Turkey, . 5
16. AKKUZU, M.; YARAŞ, S.; ÖZDOĞAN, O.; ÜÇBİLEK, E.; ATEŞ, F.; ALTINTAŞ, E.; AYDIN, F., GASTROİNTESTİNAL STENT UYGULAMALARI: TEKMERKEZ DENEYİMİ. 37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi, 2020-11-25, 2020-11-29, , Turkey, . 5
15. AKKUZU, M.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O.; ATEŞ, F.; ALTINTAŞ, E.; AYDIN, F., YAŞLI HASTALARDA PERKÜTAN ENDOSKOPİKGASTROSTOMİ DENEYİMİMİZ. 37. Ulusal Gastroenteroloji Kongresi ve 8. Ulusal Gastroenteroloji Cerrahisi Kongresi, 2020-11-25, 2020-11-29, , Turkey, . 5
14. AYDIN, F.; AKKUZU, M.; RIZAOĞLU BALCI, H.; SEZGİN, O.; ALTINTAŞ, E.; ATEŞ, F.; ÜÇBİLEK, E., Hiperkalsemiyle ilişkli Akut Pankreatit. 16. Anadolu Gastroenteroloji Günleri, 2020-09-11, 2020-09-12, Şanlıurfa, Turkey, . 7
13. ALTINTAŞ, E., Nadir Görülen Bir Olgu: İmatinip İlişkili Pankreatit. Gastroenteroloji Günleri 2020, 2020-02-28, 2020-02-29, Ankara, Turkey, . 25
12. ALTINTAŞ, E., 'Tümör Biyolojisi Işığında Optimal Yönetimi Hedeflemek. Çukurova Hepatoselüler Karsinoma Kongresi, 2020-02-27, 2020-02-29, Adana, Turkey, 2020. 25
11. ALTINTAŞ, E., postersiz. Ulusal Hepatoloji Kongresi”, 2019-05-01, 2019-05-05, Antalya, Turkey, 2019. 25
10. ALTINTAŞ, E., postersiz. Ulusal Hepatoloji Kongresi”, 2019-05-01, 2019-05-05, Antalya, Turkey, 2019. 25
9. ALTINTAŞ, E., İBS mi? İBH mı? Yoksa ikisi birden mi?. Ulusal Gastroentereloji Haftası, 2018-11-21, 2018-11-25, Antalya, Turkey, 2018. 25
8. ALTINTAŞ, E., Pankreatit hastalarında nütrisyon tedavisi. Klinik Nütrisyon Okulu,, 2018-11-01, 2018-11-04, Mardin, Turkey, 2018. 25
7. ALTINTAŞ, E., Hepatobiliyer Ultrasonografi. Hepatoloji Okulu, 2018-05-03, 2018-05-06, Muğla, Turkey, 2018. 25
6. TEZCAN ÜLGER, S.; ÖZGÜR, D.; ÜLGER, M.; YARAŞ, S.; ALTINTAŞ, E.; SEZGİN, O.; ASLAN, G., Mersin İlinde Kronik Hepatit B Hastalarında Direnç Mutasyonlarının Araştırılması. 2. Ulusal Viroloji Günleri, 2018-03-22, 2018-03-24, İzmir, Turkey, . 10
5. ALTINTAŞ, Z.; YILMAZ, İ.; ÇELİK, H.; ÜÇBİLEK, E.; YARAŞ, S.; ÖZDOĞAN, O.; ATEŞ, F., PEGİLE İNTERFERON PLUS RİBAVİRİN TEDAVİSİ İLE KALICI VİRAL YANIT GERÇEKLEŞEN G1 HEPATİT C HASTALARINDA MTHFR GEN POLİMÖRFİZMİNİN UZUN VADEDE ETKİLERİ. 34. ULUSAL GASTROENTEROLOJİ HAFTASI, 2017-12-01, 2017-12-06, , Turkey, . 2
4. DEMİR, M.; BALKAN, A.; ATEŞ, F.; ALTINTAŞ, E.; YARAŞ, S.; AKÇAER ÖZTÜRK, N.; KARA, B., Gerçek yaşamda genotip 1 kronik hepatit C’li hastalarda 3D rejimin deneyimi Çok merkezli bir çalışma. 14. Ulusal Hepato-Gastroenteroloji Kongresi, 2017-04-05, 2017-04-08, Antalya, Turkey, . 10
3. DEMİR, M.; BALKAN, A.; ATEŞ, F.; ALTINTAŞ, E.; YARAŞ, S.; AKÇAER ÖZTÜRK, N.; KARA, B., Gerçek yaşamda genotip 1 kronik hepatit C’li hastalarda 3 D rejimin deneyimi Çok merkezli bir çalışma. 14. Ulusal Hepato Gastroenteroloji Kongresi 5. Ulusal Gastroenteroloji Cerrahisi Kongresi, 2017-04-05, 2017-04-08, ANTALYA, Turkey, . 10
2. ALTINTAŞ, E., -. 1. Çukurova HCC Sempozyumu, 2017-02-10, 2017-02-12, Adana, Turkey, 2017. 25
1. ALTINTAŞ, E., -. Ulusal Gastroenteroloji Haftası, 2015-11-25, 2015-11-29, Antalya, Turkey, 2015. 25
4. ALTINTAŞ, E., Hepatosellüler kanserde sistemik tedavide immünoterapinin yeri. 38. Ulusal Gastroenteroloji Haftası, 2021-11-16, , Antalya, Turkey, . 0
3. ALTINTAŞ, E., ENTEKAVİR DENEYİMİ . Chronic Hepatitis Single Topic Conference, Kıbrıs 2021, 2021-10-23, , , TRNC, . 0
2. ALTINTAŞ, E., Akut Pankreatit: Etiyoloji, Klinik Sunum, ve Tanı . Gastro Akademisi, 2021-06-03, , , Turkey, . 0
1. Altıntaş, E., Bizim hastalıklarımızda enteral nütrisyon: Kime? Ne zaman? Nasıl? . 34. Ulusal Gastroenteroloji Haftası, 2017-12-01, 2017-12-06, Antalya, Turkey, 2017. 0
5. MLN0002-3026 Protokol Numaralı, , Project Number: MLN0002-3026 , 0 TL, Manager, Continue... 0
4. MLN0002-3030 Protokol numaralı "Ülseratif Kolit ve Crohn Hastalığı Olan Gonullulerde Subkutan Vedolizumab in Uzun Dönem Guvenliligi ve Etkililiği in Belirlendiği Faz 3b,Açık etiketli çalışma, , Project Number: MLN0002-3030, 0 TL, Manager, Continue... 0
3. An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) , projects.kurumlar.18, Project Number: LUCENT 1, 0 TL, Manager, 2021,Completed. 0
2. , projects.kurumlar.18, Project Number: , EUR, Manager, 2018,Completed. 0
1. , projects.kurumlar.18, Project Number: , EUR, Manager, 2018,Completed. 0
13. A PHASE 2A, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND OPEN LABEL EXTENSION TREATMENT IN SUBJECTS WITH MODERATE TO SEVERE CROHN’S DISEASE, , Project Number: B7981007, 0 TL, Researcher, Continue... 0
12. A PHASE 2A, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND OPEN LABEL EXTENSION TREATMENT IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS, PFIZER, Project Number: vibrato b7981005 , 0 TL, Researcher, Continue... 0
11. , projects.kurumlar.18, Project Number: , EUR, Researcher, Continue... 0
10. , projects.kurumlar.18, Project Number: , EUR, Researcher, 2017,Completed. 0
9. , projects.kurumlar.18, Project Number: , EUR, Researcher, 2017,Completed. 0
8. , projects.kurumlar.18, Project Number: , EUR, Researcher, 2017,Completed. 0
7. Aktif Crohn Hastalığı Bulunan Gönüllülerin tedavisi için Mongersen in (GED-0301)Etkililiği ve Güvenliğinin araştırıldığı Randomize,Çift Kör, Plasebo Kontrollü,Çok merkezli Faz 3 Çalışma, , Project Number: GED-031-CD-002, 0 TL, Researcher, 2017,Completed. 0
6. , projects.kurumlar.18, Project Number: , EUR, Researcher, 2017,Completed. 0
5. Crohn Hastalığı Bulunan Gonullulerde Mongersen in (GED-0301) Değerlendirildiği Faz 3,Uzun Dönem Aktif Tedavili Uzatma Çalışması, , Project Number: GED-0301-CD-004, 0 TL, Researcher, 2017,Completed. 0
4. , projects.kurumlar.18, Project Number: , EUR, Researcher, 2017,Completed. 0
3. , projects.kurumlar.18, Project Number: , EUR, Researcher, 2017,Completed. 0
2. MEDİ2070 in Etkililiği in ve Guvenliligi in Değerlendirildiği Faz 2b,Çift Kör,Çok Dozlu,Plasebo kontrollü Çalışma, , Project Number: D5170C00002 Protokol numaralı, 0 TL, Researcher, 2017,Completed. 0
1. , projects.kurumlar.18, Project Number: , EUR, Researcher, 2017,Completed. 0
17. Is there a relationship between with the side effects of DAAs and OATP gene polymorphisms? , BAP, Project Number: 2016-2-AP4-1916, 20000 TL, Researcher, Continue... 50
16. Phase 3 Randomised, Double‑blind, Placebo‑controlled Study to Assess the Safety and Efficacy of S‑888711 (Lusutrombopag) for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease (CLD) Undergoing Elective, Invasive Procedures., projects.kurumlar.14, Project Number: L-PLUS 2_Shionogi, 0 TL, Researcher, Continue... 0
15. Liver cancer registry study, projects.kurumlar.14, Project Number: 3k, 0 TL, Researcher, Continue... 0
14. a Phase 2b study evaluating treatment with MEDI2070 in Subjects with Crohn’s disease., projects.kurumlar.14, Project Number: TAKEDA_MLN0002-3026 , 0 TL, Researcher, Continue... 0
13. The Effects of LDL-R and SR-B1 Polymorphisms on Fatty Liver Disease, BAP, Project Number: 2015-AP5-1266, 420000 TL, Researcher, Continue... 50
12. , BAP, Project Number: , EUR, Researcher, Continue... 50
11. Non-alcoholic fatty liver disease with obesity as an independent predictor for stomach and colorectal cancer: a population-based prospective study., BAP, Project Number: 2020-1-AP5-4077, 540000 TL, Researcher, Continue... 50
10. Evaluation of Hepatosteatosis Using New Quantitative Ultrasound Techniques, BAP, Project Number: 2023-1-AP5-4891, 970000 TL, Researcher, Continue... 50
9. The Effects of LDL-R and SR-B1 Polymorphisms on Fatty Liver Disease, BAP, Project Number: 2015-AP5-1266, 420000 TL, Researcher, 2018,Completed. 50
8. , projects.kurumlar.14, Project Number: , EUR, Researcher, 2018,Completed. 0
7. , BAP, Project Number: , EUR, Researcher, 2018,Completed. 50
6. , projects.kurumlar.14, Project Number: , EUR, Researcher, 2017,Completed. 0
5. Evaluation of the response to the direct- acting antiviral agents on chronic Hepatitis C treatment, by real-time quantitative elastographic method. , BAP, Project Number: 2016-2-AP5-1441, 150000 TL, Researcher, 2017,Completed. 50
4. PegBase, projects.kurumlar.14, Project Number: PegBase, 0 TL, Researcher, 2015,Completed. 0
3. -, projects.kurumlar.14, Project Number: MK3034-040, 0 TL, Researcher, 2015,Completed. 0
2. IDEA p13-338, projects.kurumlar.14, Project Number: P13-338, 0 TL, Researcher, 2015,Completed. 0
1. GenC, projects.kurumlar.14, Project Number: GenC, 0 TL, Researcher, 2013,Completed. 0
7. Gizem İşgüzar, INTRAVENOUS HYDRATION TO PREVENT POSTERCP PANCREATITIS, Others, Mersin University, Completed. 400
6. Ahmet Rastgeldi, THE EVALUATION OF EFFECTIVENESS AND RELIABILITY OF TENOFOVIR AND ENTECAVIR WITH NON-INVASIVE METHODS IN CHRONIC HEPATITIS B PATIENTS, Others, Mersin University, Completed. 400
5. Serkan Yaraş, Is pain predict necrosis and severity of acute pancreatitis?, Others, Mersin University, Completed. 400
4. Sercan Yılmaz, PREDICTIVE FACTORS OF SVR IN G1 VIRAL HEPATITIS C PATIENTS, Others, Mersin University, Completed. 400
3. Rami Helvacı, Tedavi Verilmemiş Kronik Hepatit C İnfeksiyonu İle Otoimün Tirioid Arasında Anlamlı Bir İlişki Var Mıdır?: Bir Vaka Kontrol Çalışması. , Others, Mersin University, Completed. 400
2. Ebru Kelebek, LDL ve SB-1reseptör gen polimorfizmlerinin Hepatit C virüsü doğal seyrine etkisi, Others, Mersin University, Completed. 400
1. Ümit Karabulut, EARLY ORAL REFEEDİNG AND SELECTION OF INITIAL DIET IN MILD ACUTE PANCREATITIS , Others, Mersin University, Completed. 400
1. AVES, TURKISH JOURNAL OF GASTROENTROLOGY , EDITOR, - Continue. 4000
2. AVES, TURKISH JOURNAL OF GASTROENTEROLOGY , EDITOR, 2016-11-25 - 2020-01-18. 4000
3. FRONTIERS INONCOLOGY, ETIOLOGY OF HEPATOCELLULAR CARCINOMA: SPECIAL FOCUS ON FATTY LIVER DISEAS , ASSOCIATE EDITOR, - Continue. 2000
4. FRONTIERS INONCOLOGY, PROGNOSTIC VALUE OF GAMMA-GLUTAMYL TRANSPEPTIDASE TO LYMPHOCYTE COUNT RATIO IN PATIENTS WITH SINGLE TUMOR SIZE ≤ 5 CM HEPATOCELLULAR CARCINOMA AFTER RADICAL RESECTION , ASSOCIATE EDITOR, - Continue. 2000
5. FRONTIERS INONCOLOGY, SURVEILLANCE STRATEGY FOR PATIENTS WITH BCLC STAGE B HEPATOCELLULAR CARCINOMA AFTER ACHIEVING COMPLETE REMISSION: DATA FROM THE REAL WORLD , ASSOCIATE EDITOR, - Continue. 2000
6. HINDAWI, CASE REPORTS IN GASTROINTESTINAL MEDICINE , ASSOCIATE EDITOR, E-ISSN : 2090-6528, 2016-01-01 - Continue. 0
7. HINDAWI, CASE REPORTS IN GASTROINTESTINAL MEDICINE , ASSOCIATE EDITOR, 2015-11-01 - Continue. 0
8. CASE REPORTS IN GASTROINTESTINAL MEDICINE , ASSOCIATE EDITOR, ISSN : 10.1155, E-ISSN : 10.1155, 2015-01-01 - Continue. 1000
9. BAISHIDENG PUBLISHING, WORLD JOURNAL OF GASTROENTEROLOGY PHARMACOLOGY AND THERAPEUTICS , ASSOCIATE EDITOR, E-ISSN : 2150-5349, 2013-01-01 - Continue. 0
10. FRONTIERS IN ONCOLOGY, A NOVEL INFLAMMATORY-NUTRITIONAL PROGNOSTIC SCORING SYSTEM FOR STAGE III GASTRIC CANCER PATIENTS WITH RADICAL GASTRECTOMY FOLLOWED BY ADJUVANT CHEMOTHERAPY , ASSOCIATE EDITOR, 2007-01-01 - Continue. 2000
11. FRONTIERS IN ONCOLOGY, PREDICTION OF POST-HEPATECTOMY LIVER FAILURE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA BASED ON RADIOMICS USING GD-EOB-DTPA-ENHANCED MRI: THE LIVER FAILURE MODEL , ASSOCIATE EDITOR, E-ISSN : 2234-943X, 2007-01-01 - Continue. 2000
12. FRONTIERS IN ONCOLOGY, AN APPLICABLE INFLAMMATION-JOINED AND NUTRITION-RELATED PROGNOSTIC INDICATOR IN PATIENTS WITH COLORECTAL CANCER , ASSOCIATE EDITOR, 2007-01-01 - Continue. 2000
13. THE TURKISH JOURNAL OF GASTROENTEROLOGY , ASSOCIATE EDITOR, ISSN : 2148-5607, E-ISSN : 1300-4948, 2015-11-01 - 2016-11-01. 2000
14. WORLD JOURNAL OF GASTROENTEROLOGY , PUBLICATION BOARD MEMBER, E-ISSN : 1007-9327 , 2015-01-01 - Continue. 500
15. WORLD JOURNAL OF GASTROINTESTINAL PHARMACOLOGY AND THERAPEUTICS (WJGPT) , PUBLICATION BOARD MEMBER, ISSN : 2150-5349, E-ISSN : 2150-5349, 2015-01-01 - Continue. 250
16. AVES, CONTINUOUS INSULIN THERAPY VERSUS APHERESIS IN PATIENTS WITH HYPERTRIGLYCERIDEMIA-ASSOCIATED PANCREATITIS , GUEST EDITOR, - Continue. 0
17. AVES, COMPARISON OF THE EFFICACY OF ENTECAVIR AND TENOFOVIR IN REDUCING HEPATOCELLULAR CARCINOMA RISK IN CHRONIC HEPATITIS B PATIENTS: A REAL-LIFE STUDY IN TURKEY , GUEST EDITOR, - Continue. 0
18. ELSEVIER, RECTAL INDOMETHACIN WITH TOPICAL EPINEPHRINE VERSUS INDOMETHACIN ALONE FOR PREVENTING POST-ERCP PANCREATITIS - A SYSTEMATIC REVIEW AND META-ANALYSIS , GUEST EDITOR, E-ISSN : 1424-3903, - Continue. 0
19. FRONTIERS IN ONCOLOGY, PROGNOSTIC VALUE OF GAMMA-GLUTAMYL TRANSPEPTIDASE TO LYMPHOCYTE COUNT RATIO IN PATIENTS WITH SINGLE TUMOR SIZE ≤ 5 CM HEPATOCELLULAR CARCINOMA AFTER RADICAL RESECTION , GUEST EDITOR, E-ISSN : 2234-943X, - Continue. 0
20. AMERICAN SOCIETY FOR CLINICAL PHARMACOLOGY & THERAPEUTICS, CORRELATION ANALYSIS OF IL-6, IL-17, IL-21, IL-23 WITH NON-ALCOHOLIC LIVER FIBROSIS AND CIRRHOSIS , GUEST EDITOR, E-ISSN : 1752-8054, 2023-12-08 - Continue. 0
1. TURK GASTROENTEROLOJI VAKFI, AKADEMIK GASTROENTEROLOJI , EDITOR, - Continue. 1000
2. TURK GASTROENTEROLOJI VAKFI, AKADEMIK GASTROENTEROLOJI , EDITOR, - Continue. 1000
3. FERSA MATBACILIK, AKADEMIK GASTROENTEROLOJI DERGISI , EDITOR, E-ISSN : 2149-0600, 2015-01-01 - Continue. 1000
4. TURK GASTROENTEROLOJI VAKFI, AKADEMIK GASTROENTEROLOJI , ASSOCIATE EDITOR, - Continue. 500
5. FERSA MATBACILIK LTD STI, AKADEMIK GASTROENTEROLOJI DERGISI , ASSOCIATE EDITOR, E-ISSN : 1303-6629, - Continue. 500
6. FERSA MATBAACILIK LTD. STI., AKADEMIK GASTROENTEROLOJI DERGISI , ASSOCIATE EDITOR, E-ISSN : 1303-6629, - Continue. 500
7. FERSA MATBAACILIK LTD. STI., AKADEMIK GASTROENTEROLOJI DERGISI , ASSOCIATE EDITOR, E-ISSN : 1303-6629, - Continue. 500
8. AVES, CYFRA21-1 AS A SERUM BIOMARKER FOR DETECTION AND IDENTIFICATION OF FEATURES IN COLORECTAL POLYP AND CANCER , ASSOCIATE EDITOR, 2023-01-01 - Continue. 0
9. AVES, COMPARISON OF THE EXPRESSION PROFILE OF DNA MISMATCH REPAIR PROTEINS AND IMMUNE CHECKPOINT PROTEINS REGULATING T CELL FUNCTION WITH HISTOPATHOLOGICAL FEATURES IN PANCREATIC, PERIAMPULLARY/AMPULLARY AND CHOLEDOCHAL ADENOCARCINOMAS , ASSOCIATE EDITOR, 2023-01-01 - Continue. 0
10. FERSA MATBAACILIK, AKADEMIK GASTROENTEROLOJI DERGISI , ASSOCIATE EDITOR, E-ISSN : 1303-6629, 2016-12-01 - Continue. 500
11. AVES, DIRECT SPRAYING OF EPINEPHRINE ONTO MAJOR PAPILLAE FOR PREVENTION OF PANCREATITIS AFTER ENDOSCOPIC RETROGRAD CHOLANGIO-PANCREATOGRAPHY , GUEST EDITOR, - Continue. 0
1. ANNALS OF CLINICAL & EXPERIMENTAL METABOLISM , [ 2017 : 1 ] . 0
2. ANNALS OF GASTROENTEROLOGY AND TEH DIGESTIVE SYSTEM , [ 2018 : 12 ] . 0
3. CASE REPORTS IN GASTROINTESTINAL MEDICINE , [ 2018 : 16 ] [ 2019 : 10 ] . 104
4. FRONTIERS IN ONCOLOGY , [ 2019 : 3 ] . 15
5. THE TURKISH JOURNAL OF GASTROENTEROLOGY , [ 2016 : 5 ] [ 2017 : 1 ] [ 2018 : 2 ] [ 2019 : 2 ] [ 0 : 0 ] . 50
6. WORLD JOURNAL OF GASTROENTEROLOGY , [ 2016 : 4 ] [ 2019 : 1 ] [ 0 : 0 ] . 25
7. WORLD JOURNAL OF GASTROINTESTINAL PHARMACOLOGY AND THERAPEUTICS , [ 2015 : 2 ] [ 2016 : 5 ] [ 2017 : 2 ] . 36
1. AKADEMIK GASTROENTEROLOJI DERGISI , [ 2015 : 2 ] [ 2014 : 3 ] [ 0 : 0 ] . 5
1. , 2018-03-14, Yeni Delhi, India. 0
2. , , , India. 0
Getting Information
Strategic Planning
Bologna Process
European University Association
MEU Radio
Presidential Communication Center
Osym Provincial Exam Coordinator
Academic Calendar
Corporate Internal and External Evaluation Reports
Green Campus
Ad Portal